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ABSTRACT 
Transcription factor p53 is the most commonly altered gene in human cancer.  As 
a redox-active protein in direct contact with DNA, p53 can directly sense oxidative stress 
through DNA-mediated charge transport.  Electron hole transport occurs with a shallow 
distance dependence over long distances through the π-stacked DNA bases, leading to the 
oxidation and dissociation of DNA-bound p53.  The extent of p53 dissociation depends 
upon the redox potential of the response element DNA in direct contact with each p53 
monomer.  The DNA sequence dependence of p53 oxidative dissociation was examined 
by electrophoretic mobility shift assays using radiolabeled oligonucleotides containing 
both synthetic and human p53 response elements with an appended anthraquinone 
photooxidant.  Greater p53 dissociation is observed from DNA sequences containing low 
redox potential purine regions, particularly guanine triplets, within the p53 response 
element.  Using denaturing polyacrylamide gel electrophoresis of irradiated 
anthraquinone-modified DNA, the DNA damage sites, which correspond to locations of 
preferred electron hole localization, were determined.  The resulting DNA damage 
preferentially localizes to guanine doublets and triplets within the response element. 
Oxidative DNA damage is inhibited in the presence of p53, however, only at DNA sites 
within the response element, and therefore in direct contact with p53.  From these data, 
predictions about the sensitivity of human p53-binding sites to oxidative stress, as well as 
possible biological implications, have been made.  On the basis of our data, the guanine 
pattern within the purine region of each p53-binding site determines the response of p53 
to DNA-mediated oxidation, yielding for some sequences the oxidative dissociation of 
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p53 from a distance and thereby providing another potential role for DNA charge 
transport chemistry within the cell.  
To determine whether the change in p53 response element occupancy observed in 
vitro also correlates in cellulo, chromatin immunoprecipition (ChIP) and quantitative 
PCR (qPCR) were used to directly quantify p53 binding to certain response elements in 
HCT116N cells.  The HCT116N cells containing a wild type p53 were treated with the 
photooxidant [Rh(phi)2bpy]3+, Nutlin-3 to upregulate p53, and subsequently irradiated to 
induce oxidative genomic stress.  To covalently tether p53 interacting with DNA, the 
cells were fixed with disuccinimidyl glutarate and formaldehyde.  The nuclei of the 
harvested cells were isolated, sonicated, and immunoprecipitated using magnetic beads 
conjugated with a monoclonal p53 antibody.  The purified immounoprecipiated DNA 
was then quantified via qPCR and genomic sequencing.  Overall, the ChIP results were 
significantly varied over ten experimental trials, but one trend is observed overall: greater 
variation of p53 occupancy is observed in response elements from which oxidative 
dissociation would be expected, while significantly less change in p53 occupancy occurs 
for response elements from which oxidative dissociation would not be anticipated.  
The chemical oxidation of transcription factor p53 via DNA CT was also 
investigated with respect to the protein at the amino acid level.  Transcription factor p53 
plays a critical role in the cellular response to stress stimuli, which may be modulated 
through the redox modulation of conserved cysteine residues within the DNA-binding 
domain.  Residues within p53 that enable oxidative dissociation are herein investigated.  
Of the 8 mutants studied by electrophoretic mobility shift assay (EMSA), only the C275S 
mutation significantly decreased the protein affinity (KD) for the Gadd45 response 
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element.  EMSA assays of p53 oxidative dissociation promoted by photoexcitation of 
anthraquinone-tethered Gadd45 oligonucleotides were used to determine the influence of 
p53 mutations on oxidative dissociation; mutation to C275S severely attenuates oxidative 
dissociation while C277S substantially attenuates dissociation.  Differential thiol labeling 
was used to determine the oxidation states of cysteine residues within p53 after DNA-
mediated oxidation.  Reduced cysteines were iodoacetamide labeled, while oxidized 
cysteines participating in disulfide bonds were 13C2D2-iodoacetamide labeled.  Intensities 
of respective iodoacetamide-modified peptide fragments were analyzed using a QTRAP 
6500 LC-MS/MS system, quantified with Skyline, and directly compared.  A distinct 
shift in peptide labeling toward 13C2D2-iodoacetamide labeled cysteines is observed in 
oxidized samples as compared to the respective controls.  All of the observable cysteine 
residues trend toward the heavy label under conditions of DNA CT, indicating the 
formation of multiple disulfide bonds potentially among the C124, C135, C141, C182, 
C275, and C277.  Based on these data it is proposed that disulfide formation involving 
C275 is critical for inducing oxidative dissociation of p53 from DNA. 
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Biological contexts of DNA-mediated charge transport  
 
 
  
	   2 
The vast majority of intracellular deoxyribonucleic acid (DNA), the molecule that 
houses the information necessary for life as we know it, is stored within the nucleus of 
eukaryotic cells as chromatin.  The chromatin is composed of double stranded DNA 
wrapped around histone proteins, condensing the DNA in an ordered manner that allows 
for accessibility of the genetic material when needed.  Serving as the primary library of 
information in the central dogma of life, the genetic information stored within DNA is 
transcribed into single stranded ribonucleic acid (RNA), which is then translated into a 
corresponding string of amino acids to ultimately function as a protein.1  Proteins are the 
catalytic and structural workhorses of the cell, and all of the information to make these 
proteins is housed in the DNA.  With three DNA bases creating a single codon to which a 
specific amino acid is ascribed, the four DNA bases can therefore be arranged as 64 
unique 3-base combinations.  However, with only 21 naturally occurring amino acids, the 
DNA genetic code allows for redundancy.   
DNA exists intracellularly in its physiologically relevant B-form structure.  B-
form DNA conforms to a 20 Å wide right-handed double helical structure, with the bases 
stacked centrally along the helical access (grey), with the negatively charged sugar-
phosphate backbone circling the exterior (black), as represented in Figure 1.1.2  Such B-
form DNA is comprised of two antiparallel single strands of DNA that associate through 
the formation of specific hydrogen bonds among four distinct bases: adenine pairing with 
thymine via two hydrogen bonds, and guanine pairing with cytosine via three hydrogen 
bonds.3  The bases pair so that a two-membered ring purine, G or A, always interacts 
with the corresponding a one-membered ring pyrimidine, C or T, such that the width of 
this molecule is consistently uniform.2,3  Chemical structures of the individual bases are 
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FIGURE 1.1 — Structural representation of double stranded B-form DNA.  Top: The 
DNA bases are represented in a space filling model (gray) and the sugar phosphate 
backbone as a ribbon model (black), highlighting the intimae stacking of the bases.  
Middle: Looking down the helical axis of B-form DNA, (center) the extensive degree of 
overlap among the base-paired core is depicted (right, yellow), and the structural 
similarity of the stacking to graphene (left, yellow), a known charge-conducting 
substance.  Bottom: Stick representations of the four canonical DNA bases, where the 
purine adenine pairs with the pyrimidine thymine via two hydrogen bonds, and the purine 
guanine pairs with the pyrimidine cytosine via three hydrogen bonds.  
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depicted at the bottom of Figure 1.1.  Due to the base pairing geometry orienting the two 
strands not directly opposite of one another, the DNA double helix contains a wider 
major groove and a narrower minor groove.  The major groove is 22 Å wide and allows 
access to the bases, and is known to act as sequence-specific binding sites for many 
transcriptions factors.  The minor groove is much more narrow at 12 Å, making base 
access and sequence specific protein binding more difficult from this location.2 
Of greatest interest to the research conducted in the Barton laboratory is the 
ability of DNA to act as a molecular wire.  The potential for conductivity through DNA 
was first suggested in 1962, when structural characterization determined that the 
interplanar spacing of the aromatic bases in B-form DNA is similar to the spacing 
between individual sheets of graphite, a known conductive material.  This similarity of 
DNA to stacked graphite sheets could therefore form a conductive path of overlapping π-
orbitals extending parallel to the helical axis, as depicted in Figure 1.1.4  This property of 
DNA mediated charge transport (CT) was tested using many platforms and illustrated in 
ground state electrical experiments, where it was found that well stacked DNA has the 
same conductivity as charge traveling perpendicular to sheets of graphite.5  It was also 
found that the graphite-like stacked bases of DNA also allow for the conduction of both 
electrons and electron holes along the helical axes.6 
 
Long range DNA damage 
The properties of DNA with respect to its conductive ability have been probed in 
solution through the use of tethered oxidants and electrochemically through attaching 
DNA to electrode surfaces.  From the numerous investigations conducted it has been 
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determined that DNA is able to conduct both electrons and electron holes along the 
helical axis.6  DNA must be double stranded for this conductivity to occur, whereby 
single stranded, poorly stacked, oligonucleotide counterparts are unable to convey CT.  
The transport of charge in double stranded DNA is also extraordinarily sensitive to the 
integrity of the DNA base stack.  Perturbations such as a single DNA mismatch, an 
abasic site, or an oxidatively damaged base adduct severely attenuate CT.6-10  However, 
nicks in the DNA sugar-phosphate backbone do not attenuate CT, confirming that the 
conductive nature is dependent upon the base-stacking and does not involve the 
backbone.10  We have also exploited this property in electronic devices to detect base 
mismatches, base lesions, and to characterize DNA-binding proteins.11-15  These 
investigations have determined that DNA CT occurs with a shallow distance dependence, 
meaning that charge can be conducted over long molecular distances with low resistance.  
By using a variety of distally bound photooxidants, we have also measured effective CT 
through DNA over a distance of 20 nm; much longer distances for CT are expected given 
the very shallow distance dependence observed.9,12,13  Through in vitro experiments we 
have also found that oxidative damage to DNA can occur from a distance due to the 
migration of electron holes through the DNA base stack, as depicted in Figure 1.2.6-9 
The Barton laboratory has focused our studies on the properties, usefulness, and 
biological implications of long-range charge transport (CT) through DNA.  With respect 
to the research conducted herein, the focus has been on the biological context of DNA- 
mediated oxidation.  The eukaryotic genome incurs thousands of oxidative events daily 
and may arise from such sources as ionizing radiation, exogenous chemicals, and 
metabolic side products.  But how does the DNA respond to these oxidative events? 
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FIGURE 1.2 — In vitro DNA-mediated charge transport experimental construct. 
Synthetic oligonucleotide conjugated with a Rh or Ru photooxidant (red) that then 
intercalated into the double stranded DNA (blue).  Photoexcitation (hν) of the tethered and 
intercalated photooxidant abstracts an electron from the DNA, creating an electron hole 
which than equilibrates among the π-stacked bases.  Guanine doublets (yellow) within the 
DNA sequence are efficient electron hole traps due to their low redox potential, leading to 
oxidative DNA lesions at these locations.  Oxidative lesions have been observed over 200 
Å from the DNA bound photooxidant in vitro, depicted as the white flare at the far right of 
the oligonucleotide.9  
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Research in the Barton lab and other groups has found, based on DNA CT, that once 
oxidized, the electron hole within the DNA can equilibrate among the bases and localize 
to sites of low redox potential.9,16,17 
The redox potentials of the individual bases are key in determining the location to 
which electron holes will localize in oxidized DNA.  The one-electron oxidation 
potentials for the bases are as follows: C(1.7 V), T(1.6 V), A (1.42 V), and G (1.29 V).16  
With the lowest redox potential of the four canonical bases, guanine is the most easily 
oxidizable.  Guanine doublets and triplets are even more readily oxidizable than single 
guanine residues, and guanine oxidation at the 5´ end of such sites has become a known 
hallmark of one-electron oxidation of DNA.17  As shown in Figure 1.2., in vitro 
photooxidation of a long oligonucleotide shows that the electron hole preferentially 
localizes to guanine doublet sites over 200 Å away from the DNA tethered photooxidant.9  
Given the ease of electron hole migration through DNA, we expect holes to localize to 
DNA sites of lowest reduction potential: particularly guanine doublets and triplets.17  
Guanine radicals can yield a myriad of mutagenic lesions as a result of reacting with 
water or dioxygen.18   
 
Long range DNA CT in the presence of DNA-bound proteins  
One avenue of research within the Barton lab has been to explore how DNA CT 
may be used in vivo.  In accordance with the central dogma, DNA is primarily useless if 
it cannot be transcribed and subsequently translated, indicating that histone proteins or 
transcriptional proteins are continually within close proximity of DNA.1  One can 
imagine that proteins intimately involved with DNA may be able to couple into the CT 
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pathway of DNA and potentially utilize this property as a means of cellular signaling.  In 
certain cases, DNA-bound proteins may react with the base radicals to form covalent 
adducts.19  If the DNA-bound proteins are also redox active, they may be able to 
modulate their activity upon oxidation, and not become covalently attached to the DNA.  
While most studies conducted thus far have used synthetic oligonucleotides tested in 
vitro, we have also seen been able to observe that long-range oxidative damage can occur 
in chromatin and in the nucleus of HeLa cells.20-22 
One example of a protein that affects the DNA CT properties is the TATA 
binding protein.  The main function of the TATA protein kinking the DNA is to 
destabilize the bases to allow for other transcriptional machinery to access a 
transcriptional start site.23  However, the kink made by the binding of TATA protein to 
the DNA is so severe that charge transport is attenuated and can be detected 
electrochemically.  
Another transcription factor formerly studied in the Barton group includes SoxR, 
which is an E. coli stress response protein that contains a [2Fe2S] cluster.24  SoxR is a 
transcriptional regulator for the SoxS gene pathway, and the activation of SoxR only 
occurs once the protein is oxidized.  Since the SoxR protein has similar binding affinities 
for its response element in the apo, reduced, and oxidized forms, binding of SoxR to 
DNA is not the source of its oxidation.  However, it appears that only the SoxS 
downstream products are activated in the presence of oxidized SoxR and the DNA 
mediated oxidation of SoxR leads to a conformational change that elicits the transcription 
of downstream SoxS.25  Experiments in vitro have shown that SoxR can be oxidized from 
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a distance through DNA CT, leading ultimately to the transcriptional activation of 
SoxS.25 
Even more complex DNA-protein interactions have been studied and a model has 
been proposed whereby DNA CT plays an integral biological role in DNA damage, 
sensing for the first step of DNA damage repair.26  This DNA-mediated genomic repair 
process is made possible by the prevalence of [4Fe-4S] clusters in base excision repair 
enzymes, such as MutY, EndoIII, and DinG.27, 28  More recently, [4Fe-4S] clusters have 
been found in the full range of DNA-processing enzymes, suggesting a general role for 
DNA CT within the cell in long range signaling of genomic integrity.8,26  In this model, 
the proteins communicate to one another through electron injection to the DNA.  If the 
proteins can communicate, that means the intervening region between the two proteins 
has been scanned and is free of damage; in this case, the proteins can dissociate and move 
on to investigate another location within the genome.  If DNA damage is located between 
the two proteins, the scan cannot be completed due to the attenuation of CT, and both of 
the proteins remain bound within the local area.  The proteins may then process around 
that general region to find and repair the site of damage.8,26  
DNA CT recognition by proteins does not necessarily require an iron-sulfur 
cofactor; other redox-active moieties within a protein can participate as well.  Cysteine 
residues can be oxidized to form disulfide bonds at physiological redox potentials.  As 
shown both by in vitro photooxidation and electrochemical experiments, thiols 
incorporated into the DNA backbone can be oxidized to disulfides at a distance through 
long range DNA CT.29,30  Cysteine redox chemistry is often harnessed in vivo by DNA-
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bound proteins as a redox switch in regulation; DNA CT chemistry would offer the 
ability to carry out such reactions from a distance in vivo. 
 
Transcription factor p53 
Transcription factor p53 was initially thought to be an oncogene, due to its 
marked upregulation in numerous human cancers.  It was however determined that p53 is 
a transcription factor whose mutation leads to a predisposition to cancer.  Therefore, p53 
is a tumor suppressor and not itself an oncogene.  Human transcription factor p53 
transduces a variety of cellular stresses into transcriptional responses.  The pivotal role 
which p53 plays in human cells classifies this protein as a tumor suppressor.  
Intracellularly, p53 has a short half life due to its negative regulator murine double 
minute 2 (MDM2), which is an E3 ubiquitin ligase that sequesters p53 and targets it for 
proteolytic degradation through multiubiquitination.  When some cellular stress signal is 
sensed, such as oxidative stress, hypoxia, or oncogene activation, p53 is activated and 
escapes MDM2 control.  This increases intracellular p53 levels leading to the regulation 
of p53 target genes or other protein-protein interactions.  Overall, many of the pathways 
in which p53 is involved revolve around decisions of cellular fate, including responses 
like apoptosis, senescence, cell cycle arrest, or DNA repair (Figure 1.3).31-36 
The importance of p53 integrity for proper biological function is highlighted by 
the fact that mutations in this protein are observed in over half of all human cancers.  The 
most common type of mutations observed in human cancers involving mutant p53 are 
point mutations, resulting in a single amino acid substitution within the protein.37  Such 
mutations may cause improper protein folding, disruption of integral protein-protein 
interactions, or alteration of protein-DNA contacts.38  Of the known p53 point mutations  
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FIGURE 1.3 — The p53 response to cellular stress.  The p53-MDM2 feedback loop is 
the primary means of intracellular p53 regulation.  Activating signals (top) inhibit the p53-
MDM2 interaction, leading to increased intracellular p53 concentrations and the 
subsequent activation and repression of various transcriptional targets.  Under 
physiologically normal levels of cellular stress, p53 tends to promote repair processes.  
However, in the case of severe cellular stress, in which repair attempts may be futile, 
cellular senescence and apoptosis are preferentially promoted.40  
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FIGURE 1.4 — Frequency of point mutations within p53 observed in human cancers.  
The top chart represents the percent of point mutations as observed in human cancers 
(n=24,210) per individual codon.  Of the cancer relevant mutations observed, over 80% of 
these occur within the conserved DNA-binding domain.  The structural domains of p53 
are depicted below the plot.  p53 contains an N-terminal trans activation domain (TAD), 
followed by a proline rich domain (PRD), the highly conserved and structured DNA 
binding domain (DBD), followed by the tetramerization domain (TD) and the C-terminal 
domain (CTD).37  
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observed in human cancer, the majority of these mutations occur within the DNA-binding 
domain, as seen in Figure 1.4.38,39  This finding strongly suggests that the proper function 
of the DNA binding domain is of the utmost importance for proper p53 function.  Human 
p53 is the most highly researched human transcription factor due to its association with 
cancer. 
 
Structure of p53 
At 393 amino acid residues long, human p53 contains many highly conserved 
residues within the DNA binding domain.  Human p53 is comprised of a loosely 
structured amino-terminal transactivation domain (TAD—residues 1-63) containing two 
transactivation subdomains (TADI—residues 1–42, TADII—residues 43–63), to which 
many different post translational modifications can be appended.  The TAD is followed 
by a proline-rich domain (PRD—residues 64–92), which is a common feature in many 
transcription factors.  Following the PRD is a flexible and unstructured region that leads 
into the highly structured and evolutionarily conserved core of the protein, the DNA-
binding domain (DBD—residues 102–292).  The DBD is followed by the tetramerization 
domain (TD—residues 307–355), which allows for the protein to assemble as a tetramer 
when binding response element DNA.  The TD contains a flexible linker region (residues 
307–315) as well as a nuclear localization signal domain (residues 316-325).  The p53 
protein is then terminated with an unstructured basic C-terminal domain (CTD—residues 
356–393).40  This general landscape of the p53 domains is depicted in Figure 1.4.  
Corresponding point mutation frequencies at each codon of p53 as observed in human 
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cancers is also listed, demonstrating that the majority of cancer relevant mutations occur 
within the DNA binding domain of the protein.37   
Transcription Factor p53 binds to its response element as a tetramer.  The DNA 
sequence to which p53 was found to recognize and bind is comprised of two copies of the 
10 base pair half site motif 5′-RRRCWWGYYY-3′, separated by 0-13 base pairs, with R 
representing a purine, Y representing a pyrimidine, and W being either an adenine or 
thymine.41  Each monomer of p53 also contains one Zn2+ that appears necessary for 
structural integrity, allowing for response element binding.  p53 makes several direct 
contacts with bases within the major groove of the response element, as well as direct 
backbone contacts and several water-mediated contacts.  As depicted in Figure 1.4, the 
p53 DNA binding domain assembles to the response element as a tetramer.42,43  Within 
each p53 monomer, three cysteine residues (C176, C238, and C242) and one histidine 
(H179) coordinate a zinc ion that is believed to be structurally necessary for DNA 
binding.38,42-44  Located close to the Zn2+, but not participating in metal binding, is C182.  
Closer to the DNA-p53 interface are the remaining conserved residues of interest: C124, 
C135, C141, C275, and C277.  Nestled into the major groove, C277 is capable of forming 
a hydrogen bond within the purine region of the p53 response element quarter site.42,43  
C275 is located 7.0 Å away from C277, from sulfur atom to sulfur atom. Residues C124, 
C135, and C141 are found clustered deeper inside the core of the DNA binding domain, 
with C275 7.0 Å angstroms away from C135.  Chen and coworkers have reported these 
residues as reduced in their structural characterizations of the p53 DNA binding site; 
however, disulfide formation is plausible based on the proximity of these residues with 
respect to one another.42,43 
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FIGURE 1.5 — Crystallographic representation of the p53 DNA-binding domain. 
Structural representation of p53 binding as a tetramer (blue and purple) to a full response 
element.  The spherical representation of DNA and surface representation of p53 (top) 
display the tight interaction between the p53 monomers and the response element DNA.   
Looking down the helical axis of the stick figure DNA (bottom) one can see the symmetry 
of the DNA-bound p53 tetramer and how deepy it binds into the DNA major groove.  
Images based on PMID: 3KMD crystal structure.42 
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Transcriptional activity of p53 
Most commonly, p53 serves as a transcription factor in the promotion of RNA 
polymerase II transcribed genes.  Some of the most noteworthy and important genes 
under direct p53 regulation include genes playing roles in cell cycle arrest (p21, 14-3-3), 
apoptosis (pig, Bax, puma, noxa), scenescence (pai-1), and autophagy (dram).45  
Interestingly, p53 also promotes its negative regulator MDM2 and itself, p53.  The 
majority of p53 response elements cluster within noncoding regions of the genes they 
regulate; it has been found that they can be located nearly anywhere within the target 
gene locus.46  Response elements for p53 are most commonly found in the upstream 
promoter regions from the target gene transcription start site, within about 300 base pairs.  
A general trend appears and response elements tend to decrease in transactivation 
potential as they increase in distance from the transcription start site.46  In several cases, 
p53 response elements have also been found in early intronic sequences of the target 
genes, as well as within exons.46  
Once p53 binds its designated response elements, histone modifications within the 
region are necessary to relax the chromatin and enable general transcription machinery 
accessibility.  In response to DNA damage, p53 is involved in the recruitment of the 
histone variant H2A.Z, an event which is required for full activation of p21.47  The 
relationship of p53 with its most well-studied HATs, p300 and CBP, is fairly complex.48  
Once the local chromatin has been modified and remodeled, components of the 
preinititation complex may then be recruited or somehow altered to allow for the 
initiation of transcription.49  TFIID is recruited to the promoter’s TATA region to 
nucleate the formation of the PIC, followed by TFIIB, and finally by the assembly of the 
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other transcription initiation factors (TFIIF , TFIIE, TFIIH) complexed with 
unphosphorylated RNAPII.50,51  However, for many genes, such as p21, it is clear that the 
levels of p53 bound are not the sole determinant of the ensuing transcriptional 
response.52-55  
Repression of certain genes by p53 has been proposed to occur in several different 
ways.  One suggestion is that the binding of p53 to certain response elements recruits 
corepressors to the site and results in overall downregulation.  Another idea is that p53 
can secondarily inhibit expression of certain genes by promoting the activation of certain 
repressor proteins.  p53 may also bind to its response element and occupy the site so that 
other transcriptional activators cannot gain access.  Lastly, it is thought that p53 may also 
repress genes that do not contain a p53 response element through protein-protein 
interactions that inhibit the promotion of those genes.48 
 
Other roles of p53 
There are many post-translational modifications that affect p53 and how it 
functions within the cell. It has been observed that upon DNA damage, p53 is 
phosphorylated on its NTD, and such damage-inducible phosphorylation then enhances 
p300/CBP-mediated acetylation and methylation of lysine and arginine residues of the 
CTD.  Arginine methylation has also been observed in the tetramerization domain.  
Interestingly, unlike the MDM2 ubiquitination leading to p53 degradation, mono-
ubiquitination of k320 appears to be for transcriptional regulation.56,57 
Although p53 primarily serves as a transcription factor in response to cellular 
stress, many other roles of p53 have been investigated.  Such roles have been found to 
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include transcriptional repression, translational regulation, recognition of DNA double 
strand breaks, as well as playing a role in homologous recombination and enabling a 
transcription-independent apoptotic response.58-61  The C-terminal domain of p53 has also 
been suggested in specifically recognizing and binding to unique and biologically 
relevant DNA structures such as single-stranded DNA over hangs, hemicatenated DNA, 
minicircular DNA, and supercoiled DNA.62-66  
 
Focus of this thesis 
Much research has focused on the transcriptional role that p53 play through its 
recognition and binding of response element sites.  However, with each new study, the 
network of roles played by p53 just becomes more and more complex.  One facet of this 
research that has gone uninvestigated by other laboratories is determining if and how p53 
can directly sense DNA damage, seeing that it is known that p53 is activated in this case.  
What also is not greatly known is how p53 selects binding to one response element over 
another.  Also, many researchers focus on p53 recruitment, activation, and modification, 
but there is little understanding of what the deciding factor is and how p53 then returns to 
a signal-off state.  Specifically we ask how p53 senses oxidative genomic stress and 
whether p53 senses it directly.  The following work described in this thesis are 
investigations on the direct sensing of genomic oxidative stress by p53, and how it may 
accordingly respond.  While p53 is generally known to sense oxidative stress as one of its 
inputs, its function as a redox-active DNA-binding protein remains to be fully elucidated.  
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CHAPTER 2 
 
 
 
Oxidative dissociation of p53 is dependent upon response 
element DNA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from Schaefer, K. N. and Barton, J. K. (2014) Biochemistry 53, 3467−3475. 
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INTRODUCTION 
 
Human transcription factor p53 is warmly referred to as the guardian of the 
genome, since it plays a critical role in sensing cellular stress and appropriating an 
according response.  Thus far, nearly 150 genes have been identified and validated as 
being under the direct regulation of this transcription factor.1,2  For a gene to be regulated 
by p53 it must contain a p53 response element within the upstream regulatory region of 
the gene under regulatory control, typically several hundred base pairs 5′ of the 
transcriptional start site.1,2  When p53 binds to a given response element, depending on 
the gene in question, gene expression may either be activated or repressed; however, a 
recent computational analysis suggests that p53 is solely a gene activator.2,3  It is through 
N-terminal phosphorylation of cytoplasmic p53 that it is  activated, causing it to be 
transported to the nucleus, and function as a transcription factor.4  Much research on p53 
has focused on determining its transcriptional targets and untangling the intricate 
interplay of the protein signaling networks in which it is involved.  Although much work 
has been done to elucidate how p53 actively regulates genes, much still needs to be 
learned about how p53 selectively choses which genes to promote and how these 
corresponding signals are again turned off at the according time.  
As a transcription factor, human p53 is known to bind to specific genomic 
locations to regulate expression of certain genes.  The p53 response element was 
experimentally determined through immunoprecipitation and genetic mapping of DNA 
fragments bound to p53.5  From the cumulative results of 18 distinct binding sites, the 
p53 response element was determined.  The DNA sequence to which p53 was found to 
recognize and bind is composed of two copies of the 10 base pair half site motif             
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5′-RRRCWWGYYY-3′, separated by 0-13 base pairs, with R representing a purine, Y 
representing a pyrimidine, and W being either an adenine or a thymine.5  Each half site of 
the p53 response element has striking internal symmetry, and the entire response element 
is composed of four 5′-RRRCW-3′ quarter sites of alternating direction.5  The determined 
p53 response element was consistent with in vivo and in vitro studies of the time, 
suggesting that p53 is able to assemble into a homotetramer.6,7  Structural analysis via 
crystallography has also confirmed that p53 self assembles as a tetramer on response 
element DNA, with each monomer of the p53 tetramer occupying an individual             
5′-RRRCW-3′ quarter site.8  Interestingly, the construct of this response elements allows 
for hundreds of different distinct DNA sequences simultaneously conforming to this 
pattern.  The determination of the p53 response element led to an explosion of research 
seeking to determine the genes which p53 regulates as a transcription factor and the 
physiological impact cellular activity.   
In response to DNA-mediated oxidation, p53 bound to its response element DNA 
has been observed to relinquish its binding to DNA.  Investigations of the oxidative 
dissociation of p53 via DNA charge transport (CT) has led to the study of several 
synthetic and natural p53 response elements in vitro.  Oligonucleotide constructs were 
therefore designed to containin a p53 response element, flanked 5′ end with a 12 base pair 
linker, to which an anthraquinone (AQ) photooxidant is covalently appended.9  Excitation 
of AQ via irradiation abstracts and electron from the DNA, leaving an electron hole 
among the bases.10,11  The electron hole then equilibrates along the π-stacked helical axis 
and is able to oxidize DNA-bound p53, which leads to its dissociation, as depicted in 
Figure 2.1.   It  has  been  found  that  the  oxidative  dissociation of p53 in this system is  
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FIGURE 2.1 — DNA-mediated oxidation of p53 in vitro.  Schematic illustration of DNA-
mediated CT to promote oxidation and dissociation of DNA-bound p53 (green).  Distally tethered 
to oligonucleotide, AQ serves as the photooxidant to selectively oxidize DNA.  Upon 
photoexcitation, the AQ abstracts an electron from the DNA, leaving an electron hole in the DNA 
duplex that can equilibrate through the DNA to p53, resulting in protein oxidation.  The DNA-
mediated oxidation of p53 induces a change of p53, resulting in its dissociation, potentially 
through a conformational change by disulfide formation within the protein.  
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indeed DNA-mediated, since the insertion of a DNA mismatch between the AQ and the 
p53 response element ablates p53 dissociation.9  Two human p53 response elements were 
also studied using the aforementioned construct.  The first human p53 response element 
investigated was cyclin-dependent kinase inhibitor p21 (p21), which is activated by p53 
binding and is known to block cell cycle progression out of G1.12  The second human p53 
response element investigated was Gadd45, which is also activated by p53 and is 
involved in the repair of DNA damage.12  Apart from being undoubtedly controlled by 
p53, these two response elements were ideal to study, since they contain the same overall 
GC% and both sequences for p21 and Gadd45 fully conform to the response element 
constraints.5,12  The binding affinities of reduced p53 are also comparable for both p21 
and Gadd45, as determined through electrophoretic mobility shift assays (EMSA).9  
DNA-mediated oxidative dissociation of p53 as studied by EMSA determined that p53 
readily dissociates from the Gadd45 response element but remains bound to the p21 
response element under the same experimental conditions.9   
The only difference between these two response elements is the order in which 
the DNA bases are arranged, urging that the DNA sequence of the response elements 
exert a level of control over p53 in its response to oxidative DNA CT.  Interestingly, this 
sequence selectivity with regard to p53 dissociation as observed in vitro appears to 
correlate with sensical biological regulation of p53 under conditions of severe oxidative 
genomic stress.  Since Gadd45 is involved in DNA repair, dissociation of p53 in response 
to severe genomic oxidation will lead to an overall downregulation, causing the cell to 
relinquish futile repair processes.9  Concurrently, p21 promotes G1 cell cycle arrest, and 
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continued activation by p53 under severe oxidative genomic stress may lead to cellular 
senescence and possibly apoptosis.9   
Due to the contrasting p53 responses from the Gadd45 and p21 response 
elements, we set out to determine how the p53 response element can dictate whether or 
not DNA-bound p53 will respond to DNA-mediated oxidation.  Our goal is to understand 
the basis for the DNA sequence selectivity associated with the oxidative dissociation of 
p53.  To investigate this property, we constructed a variety of synthetic response element 
constructs to tune the one-electron oxidation potentials within the response element, 
while simultaneously conforming to the response element constraints.  Since guanine has 
the lowest one-electron oxidation potential of all the bases, it serves as an efficient 
electron hole trap and reactivity correspondingly increases for a guanine doublets and 
triples, a known hallmark of one-electron DNA oxidation.13,14  Once the oxidative 
dissociation of p53 in response to DNA CT was determined on the synthetic response 
elements, naturally occurring human response elements were then investigated in the 
same manner.  From the information learned herein, we were able to explore how the 
sequence context may play a role in p53 regulation more generally, enabling us to make 
predications about the response of p53 to oxidative DNA CT bound to other human 
response elements.  
 
MATERIALS AND METHODS 
Oligonucleotide synthesis and purification.  Oligonucleotides were synthesized 
on an ABI 3400 DNA synthesizer using standard solid phase phosphoramidite chemistry.  
Light control sequences (LC) not containing a photooxidant were synthesized with the 
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dimethoxytrityl (DMT) group intact.  Cleavage of the oligonucleotide from the resin and 
deprotection were conducted by incubation in NH4OH overnight at 60 °C, and 
subsequently dried in vacuo.  The oligonucleotides were purified by reversed phase C-18 
HPLC (2% to 32% acetonitrile against 50 mM ammonium acetate over 30 min) with the 
main peak collected and dried in vacuo.  DMT removal was conducted by a 15 min 
incubation of the sample solvated in 80% acetic acid.  This reaction was then quenched 
by the addition of 200 proof ethanol and 3 M sodium acetate.  Once dry, the 
oligonucleotides were subjected to reversed phase HPLC once more (2% to 17% 
acetonitrile against 50 mM NH4OAc over 30 min).   
Oligonucleotides for the anthraquinone (AQ) photooxidant tethered stands were 
synthesized with the DMT group removed.  An AQ derivative, carboxylic acid(2-
hydroxyethyl)amide was converted to its respective phosphoramidite and incorporated 
onto the 5ʹ′ end of the sequence using a 15 min coupling on the ABI 3400 DNA 
synthesizer.9-11  AQ-conjugated oligonucleotides were cleaved from the resin and 
deprotected as previously described.  The AQ-DNA was purified by reversed phase 
HPLC (2% to 17% acetonitrile against 50 mM NH4OAc over 30 min), collecting the peak 
with absorbance for both DNA at 260 nm and AQ at 365 nm.  Oligonucleotides were 
column desalted (Sep-pak, Millipore), characterized by MALDI-TOF mass spectrometry 
(Applied Biosystems Voyager DE-PRO), and quantified by UV-visible spectroscopy 
(Beckman DU7400 spectrophotometer) at their respective ε260 values.  Double stranded 
oligonucleotides were formed by thermal annealing of equimolar amounts of 
complementary single strand, heating at 90 °C for 5 min and cooling to ambient 
temperature in 5 mM sodium phosphate, 50 mM NaCl, pH 7.5.  
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Protein production.  The p53′ protein used is a full-length human p53 containing 
three stabilizing mutations: M133L, V203A, and N268D.15  The gene for p53′ was cloned 
from the quadruple mutant p53 plasmid N239Y/M133L/V203A/N268D.15  PCR 
mutagenesis by overlap extension and gene splicing was used to restore N239 and the 
sequence was verified by Laragen.16  The plasmids were propagated in DH5α cells grown 
on 2yt media (16 g tryptone, 10 g yeast extract, 5 g NaCl; per 1L) plates with 30 µg/ml 
kanamycin plates and isolated using a miniprep kit (Qiagen).  The p53′ protein was 
overexpressed and purified as described previously.17  The protein was overexpressed in 
BL21(DE3) cells 2yt media with kanamycin and grown at 37 °C to a volume of 6 L and 
an optical density at 600 nm of 0.6-0.8.  The cells were induced by 1mM of IPTG and 0.1 
mM of zinc sulphate and allowed to express for 16 hours at 22 °C.  At this point the cells 
should be pelleted by centrifugation and frozen at -80 °C.   
The cells then can be defrosted on ice and suspended in nickel column buffer (50 
mM KPi, pH 8; 300 mM NaCl; 10mM imidazole; 15 mM β-mercapto-ethanol and one 
complete protease inhibitor 1 tablet per liter) and manually homogenized.  The 
homogenized cells were then lysed via microfluidization.  The lysate was then cleared by 
centrifugation and filtered through a 0.2 micron sterile filter unit.  The protein was first 
purified by FPLC using a heparin column, using a linear gradient over 10 column 
volumes to a final concentration of nickel column elution buffer (50 mM KPi, pH 8; 500 
mM NaCl; 10mM imidazole; 15 mM β-mercapto-ethanol and one complete protease 
inhibitor 1 tablet per liter).  The isolated protein was digested overnight at 4 °C with TEV 
protease (Invitrogen) overnight to remove the appended His tag.  The protein isolate was 
then purified once more using FPLC with a heparin column, from 25 mM phosphate, pH 
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7.5, and 10% glycerol to 25 mM phosphate, pH 7.5, 1.0 M NaCl, and 10% glycerol over 
10 column volumes.  Dithiothreitol was diluted to nanomolar levels with p53 buffer (20 
mM Tris, 100 mM KCl, 0.2 mM EDTA, 20% glycerol, pH 8.0) before the protein was 
flash-frozen and stored at -80 °C.   
5ʹ′ oligonucleotide radiolabeling.  Single stranded oligonucleotides were 5ʹ′ 
labeled with 32P-g-dATP (Perkin Elmer) as described.18  Purification of the oligos via 
denaturing gel electrophoresis is essential prior to annealing.  The purified samples were 
dried in vacuo and resuspended in 5 mM potassium phosphate, 50 mM NaCl, pH 7.5. 
3ʹ′ oligonucleotide radiolabeling.  3ʹ′ radiolabeling was carried out for DNA 
strands conjugated with anthraquinone at the 5ʹ′ end.  The AQ oligonucleotides were 
radiolabeled using 32P-γ dTTP (MP Biomedicals) and Terminal Transferase (New 
England Biolabs).  The samples were mixed at standard NEB protocol conditions, 
incubated for 2 h at 37 °C, and subsequently passed through two Micro Bio-Spin 6 
columns at 3,000 RPM.  Purification of the oligos via denaturing gel electrophoresis is 
essential prior to annealing, and does not affect the tethered AQ.  Samples were purified 
as previously described and the dried purified samples were resuspended in 5 mM 
potassium phosphate, 50 mM NaCl, pH 7.5.18 
Electrophoretic mobility assay of p53′.  The p53′ protein was allowed to bind to 
the radiolabeled oligonucleotides with a 1:1 DNA:protein tetramer ratio (100 nM 1% 5ʹ′ 
radiolabeled duplex and 400 nM p53 monomer) in the presence of 5 µM competitor DNA 
(5ʹ′GGAAAAAAAAAAAAAAAAAAACC-3ʹ′)(IDT), 0.1% NP-40 (Surfact-Amps NP-
40, Thermo Scientific), and 0.1 mg/ml BSA (Fraction V, Sigma) in 20 mM Tris-HCl, pH 
8.0, 20% glycerol, 100 mM KCl, and 0.2 mM EDTA.  The concentration of p53′ used 
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was dependent upon the KD of the protein for the natural response elements, ensuring a 
minimum of 80% DNA bound with p53.  Samples were made at 4 °C and irradiated on 
ice for varying lengths of time using a solar simulator (ORIEL Instruments) with a 1000 
W Me/Xe lamp, and internal and expternal UVB/UVC longpass filters to avoid direct 
DNA strand damage.  The radioactivity of each sample was determined by scintillation 
counting (Beckman LS 5000TD) and normalized prior to loading onto a 10% TBE 
polyacrylamide gel (Bio-Rad), with the ideal intensity of 300,000 c.p.m. per hour of 
irradiation of each sample.  Each gel was run in 0.5x TBE buffer at 4 °C and 50 V for 1.5 
h.  DNA from the gel was transferred to Amersham Hybond-N nucleotide blotting paper 
(GE Healthcare) by semi-dry electroblotter (Owl HEP-1) for 1 h at 175 mA in transfer 
buffer (25 mM Tris, HCl, 200 mM glycine, 10% methanol, pH 8.5).  The blots were 
exposed to a blanked phosphorimaging screen (GE Healthcare), imaged by a STORM 
820 scanning system (Molecular Dynamics), and analyzed using Image Quant, Excel, and 
Origin.  All data were normalized to the corresponding unirradiated control, and the 
change in p53 binding was determined by monitoring the signal of free DNA over the 
total DNA signal per lane. 
Assay of oxidative DNA damage. Samples were prepared from a stock solution 
containing 1 µM 100% 32P-3ʹ′ labeled oligomer duplex on the AQ strand, 5 µM 
competitor DNA, 0.1% NP-40, and 0.1 mg/mL BSA in p53 buffer (20 mM Tris HCl, 100 
mM KCl, 0.2 mM EDTA, 20% glycerol, pH 8.0), with the titration of p53′ ranging from 
0 to 40 µM.  DNA damage was induced by sample irradiation for 1 h while in an ice-
water bath, using a solar simulator with internal and external UVB/UVC longpass filters. 
Irradiated samples were subsequently treated with a 10% piperidine (Sigma) solution 
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with 0.2 units of calf thymus DNA in water, and heated at 90 °C for 30 min to cleave 
damage sites.  Piperidine was removed by drying samples in vacuo, suspending again in 
water, and drying in vacuo once more.  The DNA was ethanol precipitated to ensure 
purity, although in retrospect this step caused the loss of our lower molecular weight 
DNA pieces.  Scintilation counting was used to ensure that equivalent levels of 
radioactivity were used in each lane.  The dry samples were resuspended in denaturing 
formamide loading buffer, heated for 2 min at 90 °C, then loaded per lane onto a pre-run 
20% polyacrylamide gel and run at 90 watts for 3 h in 1x TBE buffer.  Sequencing lanes 
were created by standard Maxam-Gilbert Sequencing reactions.19  Gels were visualized 
by phosphorimagery and quantified using ImageQuant TL and Excel.   
 
RESULTS 
p53′-DNA electromobility gel shift assays with synthetic p53 response elements.   
 The protein used in all of the following experiments is a full-length human p53 
containing three thermodynamically stabilizing mutations: M133L, V203A, and 
N268D.15  This mutant protein is designated as p53′.  The stabilizing mutations for p53′ 
were based on research from the Fersht laboratory for a stabilized yet active p53.15  For 
the three mutations in use, preliminary experiments determined that p53′ maintained its 
capacity to respond to oxidative DNA CT by dissociation.  Four synthetic DNA response 
elements were constructed and used for in vitro experiments to determine the influence of 
the guanine pattern in enabling oxidative dissociation of DNA-bound p53′ by DNA CT.  
The oligonucleotides were designed to contain the canonical p53 response element 
pattern comprised of two response element half sites with no linking bases between the 
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sites.  As seen in Figure 2.2, the response element site site is flanked 5′ with a 12 base 
pair linker to which the anthraquinone photooxidant (AQ) is covalently appended, and a 
32P radiolabel for the visualization of the DNA is located on the 5′ end of the 
complementary strand.  DNA-mediated oxidation of p53′ induces a change in protein 
affinity for response element DNA and promotes its dissociation, which we can monitor 
by EMSA.   
 The purine content of the four synthetic constructs range from containing no 
sequential guanine bases to four sets of guanine triplets, all while fully conforming to 
response element constraints.  Relative reactivity of the bases to one-electron oxidation 
varies as follows: 5′-GGG > 5′-GG > 5′-GA > 5′-AA.13,14  Dissociation constants for p53′ 
to these oligonucleotides lacking AQ are provided in Table 2.1.  The change in p53′ 
binding upon photooxidation is determined as the fraction of free DNA signal over total 
DNA signal per lane, normalized to its respective un-irradiated control, with error bars 
reflecting the standard error of the mean obtained over a minimum of three replicates.  
All samples contained 100 nM of response element DNA and 400 nM of p53′ to ensure a 
1:1 ratio of DNA to p53′ tetramer. 
 The degree of p53′ oxidative dissociation is found to vary according to the 
sequence of the oligonucleotide and is dependent upon photoexcited anthraquinone, as 
depicted in Figure 2.3.  All constructs of light control DNA strands (LC), which are 
irradiated but do not contain an appended anthraquinone for oxidation, display negligible 
dissociation of p53′.  Dissociation from all of the sequences displays a relatively linear 
trend with respect to irradiation time, with a maximum dissociation of p53′ observed after 
30 min.   Longer  irradiation  past  30  min  did  not   significantly   increase  overall   p53  
FIGURE 2.1 — Oxidative dissociation of p53 from sequences with varied oxidation potentials. A. 
DNA-mediated oxidation of p53 is induced by irradiation of an appended anthraquinone 
photooxidant. The consensus site for p53 is boxed, and the red asterisk denotes the location of the 
32P label. B. Representative autoradiogram of a p53′ electromobility gel shift assay using the 
unnatural GGG sequence. Light control samples do not have an anthraquinone photooxidant 
conjugated to the DNA, and the overall amount of DNA-bound p53′ changes minimally. The 
anthraquinone samples contain the appended photooxidant, and an increase in the amount of 
lower-molecular weight free DNA is observed with an increased level of irradiation. 
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FIGURE 2.2 — Oxidative dissociation of p53′ by EMSA from sequences with varied redox 
potentials.  Top: The oligonucleotide construct for investigating the DNA-mediated oxidation of 
p53′ contains the p53 response element.  Oxidative DNA CT is induced by irradiation of the 
appended anthraquinone photooxidant.  The red asterisk of the complementary strand denotes the 
location of the 32P label for visualization.  Bottom: Representative autoradiogram of a p53′ EMSA 
of the synthetic GGG sequence.  Light control samples do not have an anthraquinone photooxidant 
conjugated to the DNA, and the overall amount of DNA-bound p53′ changes minimally with 
irradiation.  The anthraquinone samples contain the appended AQ photooxidant, and an increase in 
the amount of lower-molecular weight free DNA is observed with respect to irradiation time. 
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a.  Locations of altered purine nucleobases in direct p53 contact are underlined in the synthetic 
constructs. 
b.  Apparent KD of p53´ was determined at 100 nM duplex, 5 μM dAdT, 0.1% NP-40, 0.1 mg/ml BSA 
in 20 mM TrisCl (pH 8.0), 20% glycerol, 100 mM KCl, and 0.2 mM EDTA and electrophoresed at 4 °C 
and 50 V on a 10% polyacrylamide gel in 0.5x TBE. 
c.  GC% of response element, not including 5′ linker. 
d.  Number of guanine doublets within the response element. 
e.  Number of guanine triplets within the response element. 
	  
TABLE 2.1 — Oligonucleotide constructs for synthetic and natural p53 response elements studied 
by EMSA. 
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FIGURE 2.3 — Oxidative dissociation of p53′ from synthetic p53 response elements.  A plot 
quantifying the percent change in p53′-DNA binding with respect to irradiation time for the four 
different synthetic response elements compared to the LC. Sequence constructs are located in 
Table 2.1.  The percent change in p53′ binding is determined as the free DNA signal over the total 
lane signal, normalized to the unirradiated control.  Error bars reflect the standard error of the 
mean over a minimum of three replicates.  Samples contained 100 nM duplex, 400 nM p53′ 
monomer, 5 µM dAdT, 0.1% NP-40, 0.1 mg/ml BSA in 20 mM TrisCl (pH 8.0), 20% glycerol, 
100 mM KCl, and 0.2 mM EDTA. 	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oxidative dissociation.  The AQ-AAA sequence confers the least amount of oxidatively 
induced dissociation of p53′ with a maximum dissociation of 7.7%.  The AQ-AGG and 
AQ GGG/GGG sequence both display similar extents of dissociation with a maximum of 
13.8% and 13.0%, respectively.  The DNA sequence that displayed the greatest amount 
of p53′ dissociation is AQ-GGG at 22.3%. Thus the highest levels of DNA CT oxidative 
dissociation of p53′ were observed from response elements with low redox potential 
guanine doublets and triplets. 
 
p53′-DNA electromobility shift assays with human p53 response elements. 
 To determine whether the gel shift results obtained from the synthetic sequences 
are applicable to naturally occurring human p53 response elements, two human p53 
response elements were also investigated: Caspase1A (CASP) and S100 calcium binding 
protein A2 (S100A2).  DNA sequence constructs using their respective response elements 
and their relative dissociation constants are also shown in Table 2.1.  Caspase1A is a 
cysteine-dependent aspartate-directed proteases and plays essential roles in apoptosis, 
necrosis, and inflammation.20  This human p53 response element promotes the production 
of caspase when p53 is bound.  The response element of Caspase1A is similar to the 
synthetic AAA sequence, with an adenine triplet within the purine region of the response 
element and no guanine doublets or triplets in either of the complementary strands.20  
Conversely, the S100A2 protein is intimately involved in cell cycle progression, cellular 
differentiation, and may function as a tumor suppressor.21,22  When p53 is bound to this 
guanine-rich sequence, S100A2 protein production is promoted.  The S100A2 response 
element is very similar to the synthetic GGG sequence, containing two guanine triplets 
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within the purine regions.  The human response elements were constructed in the same 
manner as the synthetic sequences above, with an appended 5′-anthraquinone 
photooxidant, the same 12 base linker, and the complementary strand labeled with 5′ 32P-
ATP.  The relative dissociation constant (KD) for p53 with each sequence was determined 
by gel shift assay and quantified by ImageQuant and Excel, and located in Table 2.1. 
Experiments were conducted at the protein concentration at which 80% of the 
radiolabeled oligonucleotides were bound with p53′, based upon their respective KD 
values (500 nM for the S100A2 sequence and 800 nM for the Caspase1 sequence).  As 
seen in Figure 2.3, the AQ-S100A2 sequence with two guanine triplets yields oxidative 
dissociation of bound p53′ at 14.0%, while the AQ-Caspase1 sequence yields 
significantly less oxidative dissociation, with a maximum of 6.4%.  These sequences do 
not oxidize p53 linearly with irradiation, instead leveling out at earlier irradiation time 
points. 	  
Comparison between natural and synthetic p53 response elements.   
Figure 2.5 shows the direct comparison between synthetic and natural human 
sequences.  We find that synthetic and natural response elements with varied oxidation 
potentials due to altered purine patterns within the p53 response element exhibit the 
following trend in increasing p53 oxidation: AQ-AAA, AQ-Caspase1A (red) < AQ-
GGA, AQ-GGG/GGG, and AQ-S100A2 (blue) < AQ-GGG (green).   
The AQ-Caspase1A sequence displays minimal dissociation of p53′ upon 
photooxidation, comparable to that seen with the synthetic AQ-AAA sequence.  The high 
redox potential adenine triplet within the purine region does not allow for facile transfer 
of  an electron  hole from  the  DNA to the bound p53′.   The  AQ-S100A2  sequence,  in 
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FIGURE 2.4 — Oxidative dissociation of p53′ from human response elements.  A plot quantifying 
the percent change in p53′-DNA binding with respect to irradiation time for the natural human p53 
response elements Caspase1A and S100A2.  Sequence constructs are located in Table 2.1.  The 
fraction of p53′ dissociation was determined as a ratio of the percent of bound DNA in the irradiated 
sample to that in the dark control.  Error bars reflect the standard error of the mean obtained from a 
minimum of four trials.  Samples contained 100 nM duplex, 500 nM p53 monomer for S100A2, and 
800 nM for p53 monomer CASP, 5 µM dAdT, 0.1% NP-40, 0.1 mg/ml BSA in 20 mM TrisCl (pH 
8), 20% glycerol, 100 mM KCl, and 0.2 mM EDTA. 	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FIGURE 2.5 — Synthetic and human p53 response element EMSA comparison.  Comparison of 
synthetic and natural human p53 response element DNA EMSA data.  On the right in red, AQ-
CASP1 and AQ-AAA display minimal oxidative dissociation even at long irradiation times.  The 
sequences that allow for oxidative dissociation of p53′ (AQ-S100A2, AQ-AGG, and AQ-
GGG/GGG) are compared on the left in blue.  AQ-GGG in green displays the most oxidative 
dissociation of p53′. 
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contrast, displays high levels of oxidative dissociation upon irradiation, similar to the  
AQ-AGG and AQ-GGG/GGG synthetic sequences at 30 minutes of irradiation. 
Therefore, even with different sequences the guanine pattern within the purine region of 
the response element allows for equivalent oxidative dissociation of p53′ with equivalent 
amounts of irradiation.   
 
Long range oxidative damage with and without p53′ examined by denaturing 
polyacrylamide gels.   
To determine the exact locations within the synthetic oligonucleotides to which 
the electron holes localize, denaturing polyacrylamide gels were used to determine sites 
of oxidative DNA damage.  The oligonucleotides were 3′-32P radiolabeled on the AQ 
strand for visualization, and treated with piperidine to cleave the DNA backbone at the 
site of oxidative damage.19  When compared to Maxam-Gilbert sequencing lanes and the 
un-irradiated control, the locations of DNA oxidative damage induced by photooxidation 
are observed as bands on the denaturing polyacrylamide gel.  The intensity of each 
piperidine cleavage site is measured in comparison to the total signal intensity of each 
lane.  The p53′ protein was also titrated into the samples to assess how the protein 
inhibits DNA damage.  The presence of p53′ inhibits DNA damage by transfer of the 
electron hole from the DNA to the protein, as shown in Figure 2.6 and Figure 2.7.   
Oxidative damage is apparent primarily at the 5′-G of guanine doublets and 
triplets within the response elements, as expected thermodynamically.  After an hour of 
irradiation for the AQ-AAA sequence, which lacks guanine repeats, oxidative damage is 
observed only at the single 5′-G located near the tethered oxidant; this guanine is not 
contained  within  the  response element.   Additionally,  damage  at  this  guanine  is  not 
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FIGURE 2.6 — Representative guanine oxidation gel shift assay analysis.  The four 3′ radiolabled 
synthetic response element lane profiles are displayed at varying protein concentrations.  The gels 
were analyzed using Imagequant, and each band was calculated as the percent of total lane signal. 
The dotted black line represents the unirradiated control.  The concentration of p53′ in the 
irradiated samples is varied from 0 µM (red) to 40 µM (purple) p53′ monomer.  Samples contained 
1 µM AQ-Duplex, 5 µM dAdT, 0.1% NP-40, 0.1 mg/ml BSA in 20 mM TrisCl (pH 8), 20% 
glycerol, 100 mM KCl, and 0.2 mM EDTA.  	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FIGURE 2.7 — Representative autoradiograms of the guanine oxidation gel shift assays.  The AQ-
conjugated synthetic response element oligonucleotides with a 3′ radiolabel.  Lanes 1 and 2 are the 
Maxam-Gilbert sequencing lanes corresponding to pyrimidies (C/T) and purines (A/G).  Individual 
bases are designated on the left along with the parent band (P) and the crosslinked bands (XL).  The 
dark control in lane 3 was not irradiated and contained no p53′.  The following lanes 4-9 are 
irradiated samples with varied concentrations of p53′ from 0 to 40 µM of p53′ monomer, 
respectively.  Samples contained 1 µM AQ-Duplex, 5 µM dAdT, 0.1% NP-40, 0.1 mg/ml BSA in 20 
mM TrisCl (pH 8), 20% glycerol, 100 mM KCl, and 0.2 mM EDTA.  Ethanol precipitated samples 
were suspended in formamide loading dye and run on a pre-run 20% polyacrylamide denaturing gel 
at 90 watts for 3 h in 1x TBE buffer. 
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inhibited upon addition of p53′ at any concentration.  The AQ-AGG sequence displays 
damage within the response element primarily at the 5′-GG location and at the single 
guanine located in the linker region, adjacent to the oxidant.  Upon the addition of 10-
fold excess p53′ tetramer, a full recovery of the damage within the response element 
guanine  doublet is observed.  In contrast, no recovery is observed at the single guanine in 
the linker region.  Sequences AQ-GGG and AQ-GGG/GGG both displayed the majority 
of their oxidatively induced damage at the 5′-guanine triplet site within the response 
element, with no significant damage in the linker region.  The addition of p53′ to both 
AQ-GGG and AQ-GGG/GGG mitigates DNA base damage within the response element. 
In these sequences the damage is not fully quenched by concentrations of p53′ up to 40 
µM.  
Damage was not readily observed at the purine regions near the 3′ end.  Ethanol 
precipitation of the samples may have led to the loss of these low molecular weight 
products.  In all of the sequences, some higher molecular weight products are also 
observed and can be attributed to the formation of covalently cross-linked products.  
Irradiation without the addition of p53′ gives one band which is indicative of a crosslink 
between the two DNA strands.  The higher molecular weight bands are indicative of 
possible p53-DNA crosslinks.  
 
DISCUSSION 
Sequence dependence of p53′ dissociation.  
Electron holes in DNA localize to regions of low redox potential, most notably 
guanine doublets and triplets.  Specific sequences of oligonucleotides incorporating 
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guanine doublets and triplets into the purine regions of the response element site enabled 
the study of how the guanine pattern in p53 response element binding sites influences 
oxidative dissociation of p53.  Sequences containing low redox potential guanine 
doublets and triplets enable oxidative dissociation of p53′; we refer to these as responsive 
sequences.  Figure 2.2 shows maximum p53′ dissociation from the responsive sequences 
of AQ-GGG at 22.3%, followed by AQ-AGG, AQ-GGG/GGG around 13.0%.  The AQ-
AAA sequence confers minimal p53′ dissociation of 7.7%, and we categorize this as a 
non-responsive sequence.  
Electron hole occupancy at a particular location can be described in the context of 
overall residence times.  When equilibrating along the π-stacked DNA helical axis, an 
electron hole will spend more time at a low redox potential GGG site rather than a high 
redox potential AAA site.  The finding that the AQ-GGG/GGG sequence did not yield 
the most oxidative dissociation of p53′ is noteworthy.  In the double-stranded promoter 
site, the AQ-GGG sequence has two locations in which holes can reside, while the AQ-
GGG/GGG has four.  Effectively, the electron hole density in each GGG site of AQ-
GGG/GGG is half of that of AQ-GGG, resulting in approximately half the p53′ 
dissociation as compared to AQ-GGG.   
Importantly, the location of low redox potential sites should align with the p53-
DNA major groove interface with the p53 DNA-binding domain to enable effective 
electron transfer.  Thus, not all low potential sites within a response element are expected 
to transfer an electron hole to p53′, only those in close contact with the protein.  It is 
known that CT in proteins decays exponentially with distance, highlighting the necessity 
for low reduction potential bases at the DNA-p53 interface for this process to occur.  The 
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denaturing DNA damage gels of Figure 2.6 and Figure 2.7 illustrate the necessity both of 
proper p53 contact for electron hole transfer and of the redox potentials of purines in 
contact with p53 for conferring a sensitive response.  As highlighted in the AQ-AAA and 
AQ-AGG sequences, damage does occur at the guanine in the linker region, but that 
damage is not inhibited by the addition p53′ at any concentration investigated.  The 
inhibition of DNA damage in the presence of p53 is seen only at low redox potential sites 
in the p53 response element, and therefore in contact with p53′.  Moreover, for oxidative 
dissociation of p53′ to occur, the bases in contact with p53′ must be able to initially trap 
the electron hole with an overall low redox potential.  Thus the hole localization within 
the response element ultimately dictates the response the response element will confer for 
the oxidative dissociation of p53. 
To establish whether natural p53 binding sites respond similarly to the synthetic 
ones, two sequences were studied.  The natural sequences were found to behave similarly 
to their synthetic counterparts due to similar guanine patterns in the purine region of the 
response elements.  Upon oxidation, p53′ dissociates from S100A2, which is similar to 
the responsive synthetic sequences due to the presence of two guanine triplets; S100A2 is 
thus classified as a responsive sequence.  Since p53 promotes S100A2 expression when 
bound, oxidative stress would lead to p53 dissociation and subsequent downregulation of 
the gene, resulting in diminished tumor suppressor activity.  In contrast, the CASP1 
sequence is similar to the AQ-AAA synthetic sequence.  Minimal dissociation of p53′ 
from CASP is observed upon irradiation, designating the CASP p53 response element as 
non-responsive.  Thus, upon oxidation, p53 would be expected to remain mostly bound, 
leading to the continued promotion of CASP.  The continual promotion CASP production 
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by p53 during times of oxidative genomic stress signals the cell to continue toward 
apoptosis. 
 
Making predictions about natural p53 response elements under genomic 
oxidative stress.   
We can also compare these results to our earlier work that demonstrated a 
contrasting oxidation response in p53 between recognition elements corresponding to 
Gadd45 (DNA repair) and p21 (cell cycle arrest), now known as CDKN1A.9  These p53 
binding sites contain identical G/C percentages but display different guanine patterns 
overall.  The p53-bound Gadd45 sequence can be classified as responsive, yielding 
oxidative dissociation of p53.  In contrast, little p53 oxidation was seen from the p21 
sequence, characterizing this site at non-responsive.  Figure 2.8 highlights the p53 
residues that nest in the major groove (blue: K120, S121, C277, and R280) and the bases 
of the response element with which they directly interact (black).  As a general example, 
Figure 2.8A depicts two half-sites with no intervening spacer base pairs, highlighting the 
importance of low redox potential guanines at the 5ʹ′-RRRG-3ʹ′ site in direct p53 contact 
for responsiveness.  The p53 response element is known to contain a 0-13 base pair linker 
region between the two p53 half sites; certain p53 binding sites may conform to these 
designated constraints but contain low redox potential sites that are not in direct contact 
with p53.  Figure 2.8B depicts p53 binding to a response element with a 10 base linker 
between the two half sites.  Guanine triplets located within such a linker region would be 
favorable locations for electron hole localization, but the electron holes would be 
funneled away from the direct p53 contact sites and the overall responsiveness of that site 
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FIGURE 2.8 — Response element DNA–p53 interaction.  All diagrams are representations modeled 
from the 3KMD crystal structure by Chen et al.23  A. p53 tetramer (green) bound to canonical 
response element represented by letters.  The contacting p53 residues are shown in blue and the 
nucleobases that they hydrogen bond with are noted by black letters. B.  Representation of a p53 
tetramer bound to a response element with a 10 nucleobase linker between the two half sites C. 
Representative binding of a p53 tetramer to the Gadd45 response element.  The orange circles 
indicate anticipated locations for an electron hole to localize within direct contact of a p53 monomer.  
D.  Representative binding of a p53 tetramer to the p21 response element.  The expected location of 
electron hole localization is denoted by the orange circle and located between the two half sites and 
away from direct p53 contact. 	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would therefore be decreased.  The response element sequence  for Gadd45 is shown to 
be responsive by gel shift assay in vitro.9  Figure 2.8C illustrates that the p53 response 
element for Gadd45 indeed has guanines directly aligned with the p53 contact residues, 
and these guanines enable the overall responsiveness of this p53 binding site.  The 
recognition sequence for p21 is shown in Figure 2.8D.  This p53 binding site contains a 
low redox potential guanine triplet in the complement strand, but the 5ʹ′ guanine is located 
at the interface of the two half sites, away from the contacting p53 residues in the major 
groove.  Upon oxidation, an electron hole would preferentially localize to the 5′ location 
of the guanine triplet at the interface of the two half sites, out of direct p53 contact, 
decreasing the opportunity for oxidation of p53, rendering the sequence non-responsive. 
These results enable us to make predictions regarding the responsiveness of other 
human p53 response elements to DNA CT.  Out of more than 200 known human p53 
binding sites, we focused on sequences containing the canonical 5ʹ′-CWWT-3ʹ′ in both 
half-sites.  An illustrative set of sequences, 21 which we felt confident in making 
predictions, is provided in Table 2.2.24-27  Here, we highlight several interesting p53 
response element predictions.  Non-responsive p53 binding sites include chromosome 12 
open reading frame 5 (C12orf5) and matrix metallopeptidase 2 (MMP2).27,28  For both of 
these genes, p53 serves as an activator.  Under conditions of oxidative stress, we predict 
p53 binding should not be affected by DNA CT and there should be no significant change 
in the regulation of that gene.  C12orf5 will continue to be promoted, directing the 
glycolysis pathway into the pentose phosphate shunt, while also protecting the cell from 
reactive oxygen species.27  MMP2, also predicted to be non-responsive, is involved in the  
53 
 
   
TABLE 2.2 — Predictions of p53 responsiveness to oxidative DNA CT on human response 
elements. 	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breakdown of extracellular matrix, which is useful for apoptotic processes.28   In contrast, 
responsive p53 binding sequences that have been found include damage-specific DNA 
binding protein 2 (DDB2), polo-like kinase 2 (PLK2), and protein phosphatase, 
Mg2+/Mn2+ dependent, 1J (PPM1J).29-31  In all of these cases, p53 binding promotes the 
expression of these genes.  As these sequences appear to be responsive based on the 
purine pattern, we predict p53 oxidative dissociation by DNA CT, which will decrease 
p53 occupancy and cause an overall downregulation of the corresponding gene products.  
DDB2 is necessary for the repair of DNA damage induced by ultraviolet light within the 
nucleotide excision repair pathway.29  PLK2 is a member of the polo family of 
serine/threonine protein kinases, playing a primary role in normal cell division, and is 
necessary for the G1/S transition.30  PPM1J encodes a serine/threonine protein 
phosphatase of unknown overall function.31  In all of these cases, oxidation should lead to 
overall gene downregulation, leading to lowered MMR pathway activity and tuning of 
cell cycle control. 
The pattern and location of bases in the p53 binding site have been shown to play 
a critical role in how p53 may regulate the expression of different genes under conditions 
of oxidative stress.  DNA sequences with triplet guanine sites that make contact with p53 
protein binding sites are particularly prone to activate oxidation of the bound protein 
under conditions of oxidative stress.  This protein oxidation offers another layer of 
regulatory control and a means of modifying specific proteins post-translationally to 
respond to an environmental signal.  The fact that this modification can occur from a 
distance through DNA CT is more powerful still in permitting a host of regulatory effects 
on the genome that respond specifically and chemically to the guanine radicals generated 
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with oxidative stress.  Indeed, these results illustrate another unique role to consider for 
long range CT within the cell. 
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CHAPTER 3 
 
 
 
In cellulo investigations of transcription factor p53 during 
genomic oxidative stress 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genomic sequencing conducted by the Millard and Muriel Jacobs Genetics and 
Genomics Laboratory at the California Institute of Technology. 
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INTRODUCTION 
 
Gene regulation is the primary, and most well studied, role of transcription factor 
p53 in the human cell.  It is generally accepted that gene regulation is initiated in a p53-
dependent manner through the specific binding to defined response elements in the 
upstream regulatory region of certain genes.  However, it currently remains unknown 
how p53 binding precisely results in the activation of certain genes, while simultaneously 
acting as a repressor for others.1,2  Not only does p53 regulate protein production of well 
over a hundred confirmed genes, an emerging body of data also indicates that it may also 
play a pivotal role in genome-wide and cell type-specific changes in microRNA 
expression.3  
 Since we determined that p53 dissociates from DNA via oxidative DNA-mediated 
CT and that this dissociation is dependent upon guanine bases within the response 
element in vitro, we asked whether this response correlates to p53 activity during 
genomic stress in cellulo.4  Preliminary research was conducted to determine whether this 
response correlated in cellulo by monitoring the levels of gene transcripts under p53 
regulatory control via reverse transcription (RT) quantitative polymerase chain reaction 
(qPCR).  For these experiments HCT116N cells were used since they contain a wild-type 
p53; genomic oxidative stress was induced through treatment with Rh(phi)2(bpy)3+ and 
subsequent irradiation.5  During these experiments, three p53-regulated gene products 
were monitored which had formerly been characterized in vitro by EMSA: Caspase1A 
(CASP), S100A2 (S100A), and ornithine decarboxylase (ODC).6 
Caspase1A is a cysteine-dependent aspartate-directed protease that plays essential 
roles in apoptosis, necrosis, and inflammation.7  The binding of p53 to this response 
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element promotes the production of caspase.  The response element of Caspase1A is very 
similar to the synthetic AAA sequence, with an adenine triplet within the purine region 
and no guanine doublets or triplets in either of the complementary strands.4,7  Through 
EMSA analysis, it was determined that p53 does not readily oxidatively dissociate from 
this response element, with a maximum of 6.4% dissociation upon 30 minutes of 
irradiation, as shown in Figure 3.1.4   
Conversely, the S100A2 protein is intimately involved in cell cycle progression, 
cellular differentiation, and may function as a tumor suppressor.8,9  When p53 is bound to 
this guanine-rich response element, production of the S100A2 protein is promoted.  The 
S100A2 response element is very similar to the synthetic GGG sequence, containing two 
guanine triplets within the purine regions.4  Through EMSA analysis it was observed that 
p53 does oxidatively dissociate from the response element, with a maximum of 14% 
dissociation upon 30 minutes of irradiation, as depicted in Figure 3.1.   
Ornithine Decarboxylase (ODC) is the rate-limiting enzyme in the 
decarboxylation of ornithine, a product of the urea cycle, to form putrescine.10,11  In 
healthy cells, putrescine is synthesized in small quantities since it is a necessary 
polyamine that acts as a growth factor for cell division; however, high levels of 
putrescine are cytotoxic.  When p53 is bound to the ODC response element the 
production of ornithine decarboxylase is repressed.  This response element is similar to 
the GGG/GGG synthetic sequence, containing guanine doublets and triplets in both 
complementary strands of the response element.  We experimentally observed in EMSA 
analysis that p53 oxidatively dissociates from this sequence, around 14.2% but with a 
drastically wide range of error, as seen in Figure 3.1.  
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FIGURE 3.1 — EMSA analysis (above) and corresponding preliminary RT-qPCR (below) of 
Rh(phi)2(bpy)3+-treated HCT116N cells to determine changes in p53 gene regulation.  RT-
qPCR Samples were normalized to the untreated control and the data represents the fold 
change in mRNA levels with respect to the control.  The p53 response element sequences are 
located below the plots.4,5 
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 To examine the parallels of these EMSA data in cellulo, preliminary RT-qPCR 
trials were conducted.5  The RT-qPCR results for S100A, as depicted in Figure 3.1, 
display a slight increase in gene product with irradiation without Rh treatment (-Rh).  
However, the Rh treated (+Rh) samples both showed a marked attenuation in the S100A 
gene product, even without irradiation.  This indicates that the addition of Rh may be 
interfering with other cellular processes, leading to an overall decrease in S100A 
production solely due to the presence of Rh intracellularly.  Since we did observe 
oxidative dissociation from the S100A response element in vitro, and p53 acts as a 
promoter for this gene, a correlating decrease in S100A gene product was anticipated for 
the +Rh-irradiated sample.  The +Rh-irradiated samples for S100A showed attenuation 
within error of the +Rh-unirradiated samples, indicating no significant change in gene 
regulation occurred by inducing oxidative DNA CT.   
In the case of Caspase1A, since p53 does not readily dissociate from this 
sequence in vitro, we would anticipate a continued or upregulated production of this gene 
transcript under conditions of oxidative genomic stress.  The RT-qPCR results indicated a 
slight decrease in mRNA levels in the -Rh-irradiated samples, and a slight increase in the 
+Rh-unirradiated samples.  When oxidative DNA CT was induced in the +Rh-irradiated 
samples, we observed a slight increase over the +Rh-unirradiated sample, and a much 
larger margin of variability.   
With respect to ODC, which p53 dissociated from in vitro and functions as a 
repressor intracellularly, we would anticipate the dissociation of p53 to lead to an 
increase of ODC production.  However, all experimental conditions were within error of 
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one another.  Thus, despite thorough experimentation, no conclusions could be drawn by 
RT-qPCR. 
To more directly probe the changes in p53 binding in response to oxidative DNA 
CT in cellulo, we decided to investigate the changes of p53 binding more directly through 
chromatin immunoprecipitation (ChIP).  This technique allows the isolation of genomic 
fragments in direct contact with p53, which are then quantified through qPCR.  This 
technique allows us to determine the occupancy of p53 at specific genomic locations in 
HCT116N cells under varied conditions.  To gain more insight into p53 binding in cellulo 
during oxidative genomic stress, the isolated ChIP chromatin fragments were sequenced 
(ChIP-Seq) and aligned to the human genome.  Lastly, from this ChIP-Seq data we were 
able to return to our former sets of ChIP DNA and explore other genomic sites showing 
p53 occupancy by qPCR.  
 
MATERIALS AND METHODS 
HCT116N cell growth.  HCT116N cells were cultured at 37 °C with 5% carbon 
dioxide in RPMI medium 1640 supplemented with 10% FBS, 2 mM L-glutamine, 0.1 
mM nonessential amino acids, 1 mM sodium pyruvate, 100 units/mL penicillin, 100 
µg/mL streptomycin, and 400 µg/mL Geneticin.  Two 75 cm2 flasks of HCT116N cells 
were grown in complete HCT116 media, seeded from 1 million cells from cryostorage.  
The cells were grown until nearly confluent, harvested by trypsonization, combined, and 
split among four 500 cm2 plates with 100 ml of complete media in each.  Growth was 
allowed to continue for about two more days, until a confluence of about 30% was 
reached. 
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Rhodium photooxidant. [Rh(phi)2bpy]3+ (phi= 9,10-phenanthrenequinone 
diimine) was used in the following experiments to induce oxidative genomic stress within 
the HCT116N cells. The complex was made as previously described and synthesized by 
Ariel Furst for use in the ChIP experiments.12 
[Rh(phi)2bpy]3+ treatment of HCT116N cells.  Dry Rh(phi)2bpyCl3 was 
solvated in PBS buffer, sonicated to ensure a homogenous solution, and the concentration 
determined through UV-Visible spectroscopy (ε365 = 26300 nm).  The HCT116N cells in 
a 500 cm2 plate at 30% confluence were then dosed with 10 µM [Rh(phi)2bpy]3+ (+Rh) 
and 100 µl of DMSO in a total volume of 100 ml.  The plates that were not treated with 
[Rh(phi)2bpy]3+ (-Rh) were treated with the same amount of PBS and DMSO as the +Rh 
samples.  The cells were allowed to incubate at 37 °C for 16 h to internalize the complex.  
Nutlin-3 treatment of HCT116N cells.  Nutlin-3 was used to promote the 
upregulation of p53 through inhibiting MDM2 interaction.  Following incubation with 
+Rh or -Rh, all four 500 cm2 plates were washed twice with PBS, dosed with 50 mL 10 
µM Nutlin-3 (Cayman Chemicals) in media, and allowed to incubate for 3 h at 37 °C.  An 
example western blot depicting p53 upregulation is located in Appendix Figure 3.1.  
Treatment of the plates was staggered so that the +Rh treated samples were dosed with 
Nutlin-3 an hour prior to the -Rh samples.  After 3 h of incubation in 10 µM Nutlin-3, the 
cells were washed twice with PBS and switched to 100 ml of 2.5 µM Nutlin-3 in PBS.   
Irradiation.  Samples were then irradiated for 45 minutes using a Solar Simulator 
(Oriel Instruments) equipped with a 1000W Hg/Xe lamp and an internal and external 
UVB/UVC cut-off filter.  The corresponding unirradiated sample sat underneath the 
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irradiated sample, wrapped in foil to protect it from light, with the irradiated samples 
placed at a distance of 21.5 cm from the light source. 
2-step cellular fixation.  50 mg of disuccinimidyl glutarate (DSG, Thermo 
Scientific) solvated in DMSO was freshly made and added to PBS about 10 min prior to 
completion of the cellular irradiation.  Upon completion of irradiation, the solution of 2.5 
µM Nutlin-3 in PBS was decanted from each 500 cm2 plate and the cells were washed 
once with 4 °C PBS; caution was taken to ensure that the plates did not dry out at any 
point of the procedure.  After removing the wash PBS from the plates, 60 mL of 3 mM 
DSG in PBS at 4 °C was added to each plate and fixation was allowed to proceed for 2 h 
at 4 °C. During this incubation, the plates sat directly on the metal bench-top in the cold 
room, covered with foil to prevent further light exposure, and covered with bags of ice.  
After 2h, the DSG solution was decanted and the plates were washed twice with ambient 
temperature PBS.  The cells were subsequently fixed with 70 mL of 1% formaldehyde 
(16% formaldehyde single use methanol-free ampule, Thermo Scientific) for 15 minutes 
at ambient temperature while gently shaking.  Formaldehyde crosslinking was quenched 
by the addition glycine in molar excess, and allowed to shake for 5 min.   
The doubly fixed cells were then washed twice with 4 °C PBS, followed by 10 ml 
of 0.5 mM phenylmethanesulfonylfluoride (PMSF) in 4 °C PBS, made from a 100 mM 
PMSF in isopropanol stock solution.13  The cells were then harvested by scraping and 
isolated by centrifugation.  The plates were treated once more with 10 ml of 0.5 mM 
PMSF, scraped, and combined with the fist pellet.  After a second centrifugation, the 
pelleted cells were frozen in liquid nitrogen, and stored at -80 °C.  
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Coupling of antibody to magnetic beads.  The following procedures were all 
preformed at 4 °C.  Dynabeads goat-anti-mouse IgG magnetic beads (Invitrogen), 50 µL 
per experiment, were prepared simultaneously for all replicates.  The desired amount of 
Dynabeads was placed in a 15 ml falcon tube and the volume adjusted to 15 ml with 
sterile filtered 5 mg/ml BSA in PBS.  The beads were then mixed by gentle rotation for 5 
min, magnetically collected for 5 min, and the supernatant carefully decanted.  This wash 
procedure was then repeated twice more.  The beads were then treated with 10 µl of 
monoclonal DO-7 antibody per 50 µl of Dynabeads in a total volume of 10 ml PBS with 
5 mg/ml BSA.  The antibody conjugation was allowed to precede overnight at 4 °C while 
gently rotating.   
Chromatin isolation and sonication.  The cells were removed from storage at      
-80 °C and allowed to thaw on ice in 10 ml of Farnham lysis buffer (5 mM PIPES, pH 
8.0, 85 mM KCl, 0.5% NP-40, with one complete protease inhibitor tablet per 50 ml 
(Roche)) and allow to gently rotate for 15 min.13  To isolate the nuclear pellet, the 
solution was centrifuged for 5 min at 2000 RPM, and supernatant decanted.  The nuclear 
pellet was then suspended 1.0 ml of RIPA buffer (1x PBS, 1% NP-40, 0.5% sodium 
deoxycholate, 0.1% SDS, with one complete protease inhibitor tablet per 50 mL) and 
transferred to a 1.7 ml flat bottom eppendorff tube.13  To shear the chromatin, the solution 
was then sonicated with a QSonica sonifier with microtip at 45% power for 30 sec on and 
59 sec off for 20 rounds.  To prevent heating of the sample, the sample was held within a 
-20 °C ethanol bath.  The sonicated was cleared by centrifugation in a tapered 1.5 ml 
eppendorff tube at 14,000 rpm for 15 minutes.  The supernatant was then transferred to a 
clean tube, without disturbing the pellet, and the protein concentration determined via 
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BCA assay as per manufacturer protocol.  This will yield enough sample for 3 or 4 
replicates per condition, and at least 100 µl of this solution is to be saved for input 
analysis and sonication control. 
Chromatin immunoprecipitation.  As the BCA assay incubated, the DO-7 treated 
Dynabeads were washed three times, as described above, with 5 mg/ml BSA in PBS.  At 
this point, the beads are to be equally divided into 1.5 mL eppendorf tubes respective to 
the number of samples and replicates in preparation.  To each sample, 100 µl of 5 mg/ml 
BSA in PBS, 1 mg total protein content of chromatin sonicate (as determined by BCA), 
and RIPA buffer up to 1 ml total volume were added and incubated while rotating at 4 °C 
for 16-24 h.  
To ensure equivalent sonication among all samples, 50 µl of each sample condition 
chromatin was treated with 150 µl of elution buffer (1% SDS in 0.1 M NaHCO3) and 
incubated at 65 °C overnight for crosslink reversal.13  These samples were purified with 
the Qiagen DNeasy kit, dried, and run on a 1% agarose gel in 1% TBE and ethidium 
bromide for visualization.  
Chromatin washing and elution.  Due to overnight rotation, magnetic beads may 
stick to the eppendorf cap.  The samples are briefly centrifuged and washed 5 times with 
1 ml of LiCl wash buffer (100 mM Tris, 500 mM LiCl, 1% NP-40, and 1% deoxycholate) 
with 10 min rotational mixing, and 5 min magnetic isolation.13  After the final wash, the 
beads were suspended in TE buffer (10 mM Tris, pH 8.0, 1 mM EDTA) and transferred 
to O-ring screw cap tubes.13  The beads were then magnetically isolated once more and 
suspended in 200 µl IP Elution buffer (1% SDS in 0.1 M NaHCO3) and incubated at 65 
°C for 16 h, vortexing intermittently.13 
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Purification of immunoprecipitated DNA.  To isolate and purify the 
immunoprecipitated chromatin, the solution was extracted once with 200 µl of 
phenol/CHCl3 /isoamyl alcohol (Sigma).  The mixture was vortexed thoroughly and 
centrifuged at 14,000 RPM for 10 min for phase separation.  The aqueous phase was then 
transferred to a clean eppendorf tube.  The remaining organic phase was then back-
extracted once with 100 µl of elution buffer, as above, and pooled the first aqueous 
phase.  The isolated chromatin was then purified using the Qiagen PCR cleanup kit as per 
manufacturer protocol, with the final sample eluted twice with 100 µl of buffer EB.  
Quantitative PCR reactions.  qPCR was conducted on a Bio-Rad CFX 96 real time 
PCR platform.  Individual reactions were carried out at a total reaction volume of 20 µl 
per well, in a 96 well low-profile PCR plate.  Samples were composed of 2x SybreGreen 
Supermix (Roche), 50 µM primers, 2.0 µL of ChIP DNA isolate, and the respective 
amount of water.  A two-step amplification method was used, followed by melting curve 
determination.   The qPCR procedure used was as follows: 10 min denaturing at 95 °C, 
followed by 45 cycles of 10 sec for denaturing at 95 °C, and 30 sec for annealing and 
amplification at 63 °C, reading the plate fluorescent intensity after each cycle.  The 
melting curve was determined over a range of 65 °C to 95 °C with plate reads taken at 0.5 
°C intervals.  
Quantitation of qPCR data.  These data are first analyzed by the comparative Ct 
method (ΔΔCt), determining the fold change in p53 occupancy of each sample with 
respect to its non-immmunoprcipitated control.   
 
ΔCt = Ct (ChIP sample) – Ct (Input sample) 
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ΔΔCt = [Ct (ChIP sample, Dark) – Ct (Input sample, Dark)] – 
[Ct (ChIP sample, Light) –Ct (Input sample, Light)] 
 
Samples:   (-Rh Dark) — no photooxidant treatment and uniradiated. 
   (-Rh Light) — no photooxidant treatment and irradiated. 
(+Rh Dark) — treated with [Rh(phi)2(bpy)]3+ and uniradiated. 
(+Rh Light) — treated with [Rh(phi)2(bpy)]3+ and iradiated. 
 
Once the ΔΔCT values are determined, the ratio of the target p53 site relative to the 
untreated sample can be determined by taking 2ΔΔCt.  The overall change in p53 
occupancy induced by DNA CT is determined, where positive values indicate an increase 
in p53 occupancy at the response element site and negative values indicate decreased p53 
occupancy, as described below:  
 
2[ΔΔCt (+Rh)] - 2[ΔΔCt (-Rh)] = change in p53 occupancy under oxidative DNA CT 
 
 
Genetic sequencing of genome wide p53 occupancy by chromatin 
immunoprecipitation of [Rh(phi)2bpy]3+ treated HCT116N cells.  Samples were 
prepared as described above, but the majority of the isolated chromatin sample was not 
subject to qPCR.  The concentrations of the samples were determined through Qubit 
fluorescent analysis.  The purified samples were subsequently made into Illumina 
sequencing libraries (TruSeq ChIP Sample Prep Kit, Illumina), and sequenced on the 
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Illumina Next-Gen sequencing platform using the C23KDACXX 50 base pair single 
ended flowcell.14  The determined reads were mapped to the hg19 human genome using 
the Bowtie program to create genome coverage plots.15  The data were then imported to 
and visualized through the UCSC genome browser.16  The program MACS2 was used for 
model-based Analysis for ChIP-Seq, which called peaks of statistical significance.17  
Overall, 18489 peaks were called.  Of those peaks, the top 20 were chosen to be further 
investigated by qPCR.  Digital resources for the sequencing data are located in Appendix 
3.2 and 3.3.  
 
RESULTS 
ChIP-qPCR.  
The raw data obtained by qPCR were analyzed using the ΔΔCT method over ten 
experimental replicates.  Since the addition of the Rh photooxidant influences p53 
binding, the data were first normalized to the respective irradiated controls for both the –
Rh and +Rh sample pairs.  Once each sample set was normalized to their respective 
unirradiated control, the change in p53 occupancy due to oxidative DNA CT can be 
determined through the difference observed between the –Rh sample set and the +Rh 
sample set.  It was found that the results were widely variable among all ten sample sets, 
including both increased and decreased p53 occupancy at the three investigated response 
elements.  The determined change in p53 occupancy is depicted graphically in Figure 3.2 
and corresponding values are listed in Table 3.1.  The floating bar depiction of the ChIP-
qPCR data in Figure 3.2 depicts the 25th and 75th percentiles of the observed data in the 
boxed region, while the whiskers represent the 5th and 95th percentiles, and the solid bar  
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FIGURE 3.2 — Floating bar plot of ChIP-qPCR experimental results.  The floating bar 
depiction of the column of boxed data represents the 25th and 75th percentiles, while the 
whiskers represent the 5th and 95th percentiles.  The solid bar within the box represents the 
median value. 
TABLE 3.1 — Change in p53 occupancy for the +Rh–irradiated samples as determined by 
the ΔΔCT method.  
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within each box represents the median value.   
In the case of the p21 response element (red in Figure 3.2), we anticipated to 
observe minimal p53 dissociation based upon results observed in EMSA assays, 
corresponding to a minimal change in p53 occupancy.  As normalized to the -Rh-
unirradiated control, we observe p53 dissociation in the +Rh unirradiated sample, and 
both increased and decreased p53 occupancy within the -Rh irradiated control.  When 
determining the overall fold change in occupancy with respect to oxidative DNA CT, we 
observe what appears to be a reasonable average of the two controls, with the majority of 
the samples being within limits of the dark and untreated control.  The maximum fold 
decrease for p21 was determined at -0.209 and a maximum increase at +0.35, giving a 
total range of change of 0.559.  
With respect to the Gadd45 response element (blue in Figure 3.2), we anticipated 
observing a large trend toward decreased p53 occupancy, since p53 readily dissociates 
from this response element in vitro.  Overall, with respect to the unirradiated controls, the 
change in p53 occupancy based upon oxidative DNA CT was a dramatically varied 
distribution of both increased and decreased p53 occupancy.  However, it appears that the 
majority of the replicates displayed decreased p53 occupancy.  The maximum fold 
decrease for Gadd45 was determined at -0.437 and a maximum increase at +0.575, giving 
a total range of change of 1.048.   
For the S100A response element (green), we anticipated a large trend toward 
decreased p53 occupancy, since p53 dissociation was observed in virto.  Overall, an 
extraordinarily variable change in occupancy is observed, with both increased and 
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decreased occupancy.  The maximum fold decrease for Gadd45 was determined at -1.001 
and a maximum increase at +0.849, giving a total range of change of 1.85. 
ChIP-Sequencing.   
One set of ChIP samples were run on the Illumina Nex-Gen sequencing 
platform, comparing the four samples conditions against input, not immunoprecipitated, 
samples.  The determined fragments were correspondingly mapped to the hg19 human 
genome, allowing us to observe density reads, as well as fold enrichment.15-17  Links to 
these data are located in Appendix 3.2.  Using a Model-based Analysis for ChIP-Seq, 
18489 peaks of statistically significant chromatin enrichment were called.  Of those 
peaks, the top 20 were investigated, p53 response elements determined, and then p53 
occupancy investigated by qPCR in our former sets of ChIP isolates.  For the genomic 
locations of interest, the response elements within them are located in Table 3.2.  qPCR 
analysis was conducted upon four ChIP chromatin sets.  The results for these enriched 
sequences also displayed significant variations in p53 occupancy, both increased and 
decreased.  These data and variability determined are depicted in Table 3.3, and the 
corresponding primer sequences used in this analysis are located in Appendix table 3.1.  
These results led us to conclude that using ChIP qPCR to determine p53 occupancy in 
cellulo is a difficult task with inherent variability too large to successfully achieve our 
desired goal of monitoring p53 function in response to oxidative genomic stress. 
 
DISCUSSION 
Although the ChIP-qPCR result for Gadd45, S100A, and p21 were highly 
variable, and showed increased p53 occupancy on the response element sites 
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when only decreased p53 occupancy was anticipated, one interesting trend did 
emerge.  In the case of S100A and Gadd45, the two response elements from 
which oxidative dissociation was observed in vitro, we observed a wide range of 
decreased and increased p53 occupancy.  For Gadd45, we observed change in 
p53 occupancy from -0.437 to +0.575; a range of change of 1.048.  For S100A, we 
observed even wider changes in p53 occupancy from -1.001, and the maximum and 
median values determined over the ten experimental replicates were both 
negative values, suggesting a slight preference toward p53 dissociation.  
However, on the sequence that we did not anticipate dissociation from, p21, we 
observed a much more narrow range than in the change of p53 occupancy.  For 
p21, we observed change in p53 occupancy from -0.209 to +0.35, a range of change 
of 0.559.  For the p21 response element, the determined median value was 
positive, suggesting p53 does not preferentially dissociate from this sequence.  
Although a well-defined response of p53 to genomic oxidative stress has yet to 
be observed in cellulo, our results via ChIP-qPCR may suggest that our 
predications about responsiveness based on response element DNA sequence 
may be valid.  We can correlate the predicted responsiveness of a p53 response 
element to an increased amount of variability of p53 occupancy in cellulo during 
oxidative genomic stress.  As for the response elements we would anticipate to 
be not responsive, substantially less variability in p53 occupancy will be 
observed at those response elements under oxidative genomic stress.  However, 
determining whether an increase or a decrease in p53 occupancy will occur 
remains elusive.  
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  TABLE 3.2 — Significant peaks as determined by ChIP-Seq and evaluated by ChIP-
qPCR. p53 response elements located within most significant peaks as determined by 
ChIP-Seq.analysis.  qPCR was used to determined the relative p53 occupancy determined 
for the +Rh–irradiated samples as calculated by the ΔΔCT methods with green indicating 
increased occupancy and red indicating decreased occupancy.  
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The genomic sequencing of one set of ChIP DNA samples revealed to us a 
large pool of information about the DNA to which p53 binds.  Overall, more than 
18,000 genomic locations were found to be enriched by anti-p53 ChIP.  Aligning  
the data to the human genome (hg19), we were able to compare the overall 
enrichment, over the non-immunoprecipitated input sample, of the four sample 
conditions in comparison to one another.  It was evident in these profiles that 
increases in genomic material around certain response elements also occurs in 
the +Rh-irradiated samples, as compared to the respective controls.  This finding 
confirms that the increased occupancy observed in the ChIP-qPCR experiments 
is a real phenomenon. 
From the best peaks determined through the MACS2 program, most were 
found to contain p53 response element DNA patterns within those genomic 
locations, and primers were designed to conduct qPCR on these new sites of 
interest.  Of the samples determined through sequencing and re-evaluated in the 
ChIP samples, we again observed large ranges of variability among the four 
sample sets tested, and continued testing was felt to be futile. 
These results highlight the intricacies of transcription factor p53 gene 
regulation and the level of complexity and variation that can occur in cellulo.  
The study of p53 in cellulo has been complex, extensive, and left us with more 
questions than answers.  There is much still to be learned about the role of p53 in 
response to genomic oxidative stress and how it interacts with DNA.  Before 
further in cellulo experiments are undertaken, a cleaner approach to inducing 
DNA CT must be devised.  These studies merely confirm the eloquently stated 
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words by Karen H. Vousden and Carol Prives: “If genius is the ability to reduce 
the complicated to the simple, then the study of p53 makes fools of us all.”18 
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Appendix 3.1 — Example gel shift of upregulation of p53 via Nutlin-3 treatments (top).  
Example of sonication gel of chromatin prepared for ChIP (bottom).   
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Appendix 3.2 
 
The following libraries are on the flowcell C23KDACXX, which is a 50 base pair 
single ended flowcell: 
Lane : (Library Id) Library Name (Cluster Estimate) 
Lane #4 : (13682) index # 10 Rh Dark HCT116N p53 (None) 
     https://jumpgate.caltech.edu/library/13682 
Lane #4 : (13683) Index #11 Rh Light HCT116N p53 (None) 
     https://jumpgate.caltech.edu/library/13683 
Lane #4 : (13679) Index # 4 Input of HCT116N ChIP (None) 
     https://jumpgate.caltech.edu/library/13679 
Lane #4 : (13680) Index #5 Untreated Dark HCT116N p53 (None) 
     https://jumpgate.caltech.edu/library/13680 
Lane #4 : (13681) Index #7 Untreated Light HCT116N p53 (None) 
       https://jumpgate.caltech.edu/library/13681 
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Appendix 3.3 
 
Genome browser data: 
http://genome.ucsc.edu/cgi-
bin/hgTracks?db=hg19&hgct_customText=track%20type=bigWig%20name=%22Input%22%20visibility=full%20color=64,64,64%2
0bigDataUrl=http://cheget.caltech.edu/~igor/tempHtml/KatieSchaefer/13679_input.wig.bigWig 
 
http://genome.ucsc.edu/cgi-
bin/hgTracks?db=hg19&hgct_customText=track%20type=bigWig%20name=%22Untreated_dark%22%20visibility=full%20color=12
8,0,128%20bigDataUrl=http://cheget.caltech.edu/~igor/tempHtml/KatieSchaefer/13680_untreated_dark.wig.bigWig 
 
http://genome.ucsc.edu/cgi-
bin/hgTracks?db=hg19&hgct_customText=track%20type=bigWig%20name=%22Untreated_light%22%20visibility=full%20color=12
8,0,0%20bigDataUrl=http://cheget.caltech.edu/~igor/tempHtml/KatieSchaefer/13681_untreated_light.wig.bigWig 
 
http://genome.ucsc.edu/cgi-
bin/hgTracks?db=hg19&hgct_customText=track%20type=bigWig%20name=%22Rh_dark%22%20visibility=full%20color=0,128,0%
20bigDataUrl=http://cheget.caltech.edu/~igor/tempHtml/KatieSchaefer/13682_rh_dark.wig.bigWig 
 
http://genome.ucsc.edu/cgi-
bin/hgTracks?db=hg19&hgct_customText=track%20type=bigWig%20name=%22Rh_light%22%20visibility=full%20color=0,0,128
%20bigDataUrl=http://cheget.caltech.edu/~igor/tempHtml/KatieSchaefer/13683_rh_light.wig.bigWig 
 
Fold enrichment tracks:  
http://genome.ucsc.edu/cgi-
bin/hgTracks?db=hg19&hgct_customText=track%20type=bigWig%20name=%22Untreated_dark_FE%22%20visibility=full%20colo
r=128,0,128%20bigDataUrl=http://cheget.caltech.edu/~igor/tempHtml/KatieSchaefer/untreated_dark_gb_FE.bigWig 
 
http://genome.ucsc.edu/cgi-
bin/hgTracks?db=hg19&hgct_customText=track%20type=bigWig%20name=%22Untreated_light_FE%22%20visibility=full%20colo
r=128,0,0%20bigDataUrl=http://cheget.caltech.edu/~igor/tempHtml/KatieSchaefer/untreated_light_gb_FE.bigWig 
 
http://genome.ucsc.edu/cgi-
bin/hgTracks?db=hg19&hgct_customText=track%20type=bigWig%20name=%22Rh_dark_FE%22%20visibility=full%20color=0,12
8,0%20bigDataUrl=http://cheget.caltech.edu/~igor/tempHtml/KatieSchaefer/rh_dark_gb_FE.bigWig 
 
http://genome.ucsc.edu/cgi-
bin/hgTracks?db=hg19&hgct_customText=track%20type=bigWig%20name=%22Rh_light_FE%22%20visibility=full%20color=0,0,1
28%20bigDataUrl=http://cheget.caltech.edu/~igor/tempHtml/KatieSchaefer/rh_light_gb_FE.bigWig 
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Appendix 3.4 — qPCR primers for peaks determined through ChIP-Seq. 
 
 
Peak Forward Primer (5´-3´) Reverse Primer (5´-3´) 
1 ATGCCCAGGCATGTCCCAGCTT ACGCACTGGGCTTCTACTGCTGTGT 
2 ACGTGCGTGGTAGCAGGTGGTCTGCTT ACGTGCGTGGTAGCAGGTGGTCTGCTT 
3 TCCTCCCGTGCACAAGGCGTGAACT GCAAATGAGGGAACCTGCCCAGGGCTT 
4 TCCTGTCTCCATTGGCTGGAACTGGACC CCTAGTCTGCCTGGATCTGCCTGGACA 
5 TGTCCCTGGGTGTCTGCATCTGCGT ACTCGGGCGTTCTCTCCATGCCTCAGA 
6 TGGTAATGCCTTCTCTGGAACTTTGCCTGC TGCTGGCATGTCCCAACATGTCCCAA 
7 GCCTATGTGTGTAGGAGGCTAGACCATCTAGGTTT TGCACGGGCTGCATTCATGCCTCA 
8 CCAGACGTTCAAGACCAGCCTGGGCAA ATAGCTGGGCCCACAGGCATGTCCCAA 
9 TCCCTGTGTCTAGGGTTGGACTGCACA TCCAGCCTGCCAACAACTCTCCCACT 
10 TCCGCTCTGATTGTGCCCTGACATGC CCCGCATGCAGCTTCTGTTCCTGTGT 
11 AGACGAGACTAAGGGTTCATATAATGGGTCAGGGT ACCAGTCAGCAGCACCACAAAGGTACGCA 
12 CCCTTCTCCACCCGCAAAGAGAGCA CCCTTGTACCATGGTCTTCCAAGAATTAACCC 
13 AGCCTGGAATGCTGAAACCCTCTTAGACTGAA AGTACGGAATGTGGAATTCTGAGCCTAAACCGT 
15 TCCATTGGCTGGAGCCAGACCTCACA TCCTTGTACCTTAGTCAGAATATTCGTGCTGGACA 
17 ATGCCTGGGCATGCCTATGGTCCCAGT CCTCCTGCCTCAGCCTCTTGAGCAACT 
19A AATCCGGTCAGGCAGGCAGTTAGGGTG TCCATTGCGGGCATGTCTGGGCAAGT 
19B GCCCACAGCTGCACAGACAAGAAAGCC ATTGCGGGCATGTCTGGGCAAGTCACC 
20 TGTTTGTCTGGAGCTTTGCCTGGGACAC CATGGACCCTTGCAACCTGCTTAGCCA 
21B GCTGCATGCGCCCTTTGGTGGTTGA GGAGACTTCTTGACTTGTGGGCAACAACTTCCT 
 
	  
 
 
 
CHAPTER 4 
 
 
 
Oxidation of p53 through DNA charge transport involves a 
network of disulfides within the DNA-binding domain 
 
 
 
 
 
 
 
 
Adapted from Schaefer, K. N., Geil, W. M., Sweredoski, M. J., Moradian, A., Hess, S., 
and Barton, J. K. (2015) Oxidation of p53 through DNA Charge Transport Involves a 
Network of Disulfides within the DNA-Binding Domain. Biochemistry 54, 932–941. 
 
 
KNS and WMG produced the protein mutants and conducted EMSA experiments; KNS 
conducted mass spectrometry sample preparation; MJS, AM, and SH conducted mass 
spectrometry on QTRAP 6500 and acquired data; and KNS analyzed data.   
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INTRODUCTION 
Transcription factor p53 is one of the most heavily studied human proteins due to 
its marked prevalence of mutation in human cancer.  Over half of all human cancers 
display mutations in the p53 gene, with the vast majority of these mutations localized to 
the DNA-binding domain, as seen in Figure 4.1.1-3  Although much research has been 
conducted on this protein and its many roles within the cell, the precise mechanisms by 
which p53 senses cellular stresses and influences cellular fate are still largely unknown.  
We have previously shown that DNA-mediated charge transport (CT) can sequence 
selectively promote the oxidative dissociation of p53 bound to DNA.4,5  Here, we 
examine the mechanisms by which DNA-mediated oxidation is sensed by p53 and how 
the resulting dissociation from DNA occurs.  
A major focus of our laboratory has been the characterization of long-range 
charge transport through DNA.6-10  We have found that oxidative damage to DNA can 
occur from a distance because of the migration of electron holes through the π-stacked 
bases.  Ground state CT has been observed to occur over 100 base pairs (34 nm) through 
DNA, and oxidative damage products have been observed over 200 Å away from a DNA 
tethered photooxidant.11,12  However, perturbations in the intervening base pair stack, 
such as abasic sites and base mismatches, severely attenuate DNA CT.  In a cellular 
environment, oxidative damage can occur by reactive oxygen species attacking DNA, 
and we have found that oxidative DNA damage can also occur from a distance in vivo.6,7  
The one-electron oxidation potential of guanine is the lowest of the bases (+1.29 V), 
therefore making it the most readily oxidized base.13-16  Thus a known hallmark of DNA 
CT oxidation is the formation of DNA damage products at 5ʹ′ guanines of guanine 
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doublets and triplets.17  However, certain amino acid functional groups possess lower 1-
electron oxidation potentials than guanine and could thermodynamically be oxidized in 
DNA-bound proteins, behaving as mild reducing agents.13  The residues and their 
corresponding one-electron oxidation potentials at pH7 are as follows: cysteine (+0.9 V), 
tyrosne (+0.9 V), tryptophan (+1.0 V), and histidine (+1.2).13  Notably, the oxidation of 
cysteine residues within close proximity can lead to the formation of a disulfide bond, 
which may induce a substantial conformational change within proteins. 
To determine whether the chemistry of thiol groups near DNA could be 
modulated via DNA CT, thiols and disulfides located near the DNA base stack were 
investigated. Electrochemistry experiments on a graphite surface have shown that 
disulfide moieties covalently modified into the backbone of surface-bound 
oligonucleotides can be reduced to the corresponding thiol groups through the application 
of a reducing potential.18  Additionally, DNA CT induced by a distally bound 
anthraquinone (AQ) photooxidant is able to promote the oxidation of neighboring thiol 
groups incorporated into the backbone of an oligonucleotide into a corresponding 
disulfide bond.19   
DNA-mediated oxidation via AQ excitation leads to the dissociation of p53 from 
its response element DNA.  Unlike other redox active proteins studied in the Barton 
group, p53 does not contain an FeS cofactor and its redox activity appears to be conferred 
through a network of cysteine residues within the DNA binding domain.  An intriguing 
feature of p53 is that it contains 10 cysteine residues within the DNA-binding domain, 
nine of which are highly conserved.2  These cysteines are purported to play a variety of 
roles, including tetramer formation, Zn2+ binding, and sequence-specific interaction with 
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FIGURE 4.1 — The frequency of p53 point mutations observed in cancer.  The cysteine 
residues within p53 are noted in red.  The numbers corresponding with each residue note the 
number of cancer observed with point mutations at that codon, and the percent of which these 
mutations constitute the observed p53 point mutations.3	  	  A	  representation	  of	  the	  p53	  structural	  domains	  are	  depicted	  below	  the	  plot,	  giving	  a	  general	  idea	  of	  the	  location	  of	  these	  mutations.	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the p53 response element, as depicted in Figure 4.2.  Each orange sphere represents the 
sulfur atom of the cysteine residues present within the protein.  Within each p53 
monomer, three cysteine residues (C176, C238, and C242) and one histidine (H179) 
coordinate a zinc ion that is believed to be structurally necessary for DNA binding.2, 20-22  
Located close to the Zn2+, but not participating in metal binding, is C182.  Closer to the 
DNA-p53 interface are the remaining conserved residues of interest: C124, C135, C141, 
C275, and C277.  Nestled into the major groove, C277 is capable of forming a hydrogen 
bond within the purine region of the p53 response element quarter site.20-22  C275 is 
located 7.0 Å away from C277, from sulfur atom to sulfur atom. Residues C124, C135, 
and C141 are found as a cluster situated deeper into the core of the DNA binding domain, 
with C275 7.0 Å away from C135.  Chen and coworkers have  reported these residues as 
reduced in their structural characterizations of the p53 DNA binding site; however, 
disulfide formation is plausible based on the proximity of these residues with respect to 
one another.21-22   
One can imagine these conserved cysteine residues electronically coupling to 
promoter site DNA and playing a role in the redox modulation of p53.  A model of p53 
oxidation in response to DNA CT is illustrated in Figure 4.2.  Oxidation of p53 is 
initiated at a distance by the photoexcitation of AQ covalently tethered to DNA, injecting 
an electron hole into the DNA base stack.4,5,23  This oxidizing equivalent is then shuttled 
through the π-stacked base pairs and localizes to sites of low redox potential.  If the 
electron hole localizes to a site to which protein is bound, such as the p53 response 
element, the hole can oxidize the lower redox potential amino acid residues within close 
proximity  to  the  DNA.   This  oxidation  of  p53  leads  to  dissociation  from  the DNA, 
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FIGURE 4.2 — Schematic illustration of p53 oxidation through DNA-mediated charge 
transport.  Oxidation is initiated by AQ excitation, causing it to abstract an electron from 
DNA.  This electron hole equilibrates among the π-stacked bases, ultimately localizing to a 
low redox potential guanine site.  If the trapped electron hole localizes to the DNA-p53 
interface the bound p53 protein may be oxidized, due to amino acids with lower one-electron 
oxidations potentials than guanine.  The oxidation of DNA-bound p53 causes the formation of 
a disulfide bond and leads to the dissociation from DNA.  The orange spheres represent the 
sulfur atoms of each cysteine residue within the p53 DNA-binding domain, making them 
candidates for oxidation via DNA CT and subsequent disulfide formation.  The DNA-p53 
interface is examined in greater detail in the corresponding boxed region to the right.  This 
diagram depicts the nine conserved cysteine residues within a DNA-bound p53 monomer in 
relation to one another and the DNA based on the 3KMD crystal structure.21	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ultimately altering gene regulation in response to genomic stress while leaving the DNA 
undamaged.5   
Experiments using electrophoretic mobility shift assays (EMSA) have determined 
that p53 responds selectively to oxidation via DNA CT, causing the protein to dissociate 
from various promoter sites. We have determined that the location of the guanine 
residues within a p53 response elements is what dictates whether DNA-bound p53 can be 
oxidized through DNA CT.5  This sequence selectivity in DNA-mediated oxidation of 
p53 indicates an element of control, causing oxidative dissociation of p53 when bound to 
certain promoter sites but not to others.  This selectivity in response to DNA CT 
seemingly correlates with the biological regulation of genes controlled by p53 under 
conditions of oxidative stress. 
Several groups have worked to investigate the intricacies of p53 oxidation at a 
molecular level, an area of which little information is known after more than 30 years of 
research.  The idea of redox modulation of p53 first arose in work showing that p53 can 
bind promoter sites selectively under reducing conditions, but not under oxidizing 
conditions.24  More recently, Fersht and coworkers investigated the reactivity of cysteine 
residues by alkylation in an effort to stabilize mutant p53 observed in cancer.25  Using 
nanospray ionization (nESI) mass spectrometry, they determined that C141 and C124 
react first with alkylating agents and are therefore the most reactive cysteine residues, 
followed by C135, C182, and C277.  Landridge-Smith and coworkers have utilized top-
down and middle-down Fourier transform ion cyclotron resonance (FT ICR) mass 
spectrometry to determine the reactivity of cysteine residues within p53 oxidized by 
H2O2.26  They determined that C182 and C277 exhibit significant modification with N-
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ethylmaleimide and were deemed the most reactive residues.  However, the high 
reactivity of these residues was determined to be primarily due to their high solvent 
accessibility, which may not be the dominant factor in DNA-bound p53 oxidation in vivo.  
Work has also been done to map oxidized cysteine residues in H2O2-treated p53 by nESI 
FT ICR mass spectrometry.27  This work showed that oxidation of the p53 core domain 
by H2O2 caused a loss of Zn2+ binding within p53, with corresponding formation of two 
disulfide bonds among C176, C182, C238, and C242.  Our laboratory found using 
MALDI-TOF mass spectrometry that DNA-mediated oxidation of p53 might proceed via 
formation of a disulfide bond involving C141 and an undetermined second cysteine.4 
Here, we continue to investigate p53 cysteine oxidation promoted at a distance 
through DNA CT.  Specifically, we aim to resolve the interplay of cysteine oxidation 
within the p53 DNA-binding domain through the study of p53 mutants.  Using EMSA, 
we investigate the effect of select p53 mutations on DNA binding affinity as well as the 
ability to undergo oxidative dissociation from the Gadd45 promoter site.  The Gadd45 
promoter site was chosen since p53 is known to readily bind this sequence and also 
readily dissociates upon oxidation via DNA CT.4  To determine if oxidative dissociation 
of p53 occurs concurrently with disulfide bond formation and probe the specific residues 
involved, we employed a differential thiol labeling technique targeting cysteine residue 
oxidation states through the use of isotopically distinct iodoacetamide labels.  The 
sequentially labeled samples were proteolytically digested, and labeled peptide fragment 
intensities were examined on a QTRAP 6500 LC-MS/MS and directly compared. 
Through this methodology, we are able to characterize the redox states of individual 
cysteine residues and observe disulfide formation within p53 oxidized at a distance 
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through DNA CT.  
 
MATERIALS AND METHODS 
Synthesis and modification of oligonucleotides.  DNA was synthesized using 
standard solid phase automated synthesis, modified with anthraquinone (AQ), and 
radiolabeled as described previously.4,5,23,28  The DNA used in the following experiments 
contains the Gadd45 promoter site (underlined) with a 12 base 5′ linker. Constructs both 
without photooxidant (light control, LC) and with AQ were made.  AQ: 5′-AQ- AAA 
TCA GCA CTA CAG CAT GCT TAG ACA TGT TC-3′.  LC: 5′- AAA TCA GCA CTA 
CAG CAT GCT TAG ACA TGT TC-3′.  Complement: 5′- GAA CAT GTC TAA GCA 
TGC TGT AGT GCT GAT TT -3′. 
Protein preparation.  The p53′ protein is a full-length human p53 containing 
three stabilizing mutations: M133L, V203A, and N268D.29  All subsequent mutants 
studied are in addition to the p53′ mutations and incorporated by site-directed 
mutagenesis (QuikChange II, Agilent) with resulting sequences verified by Laragen 
(primer sequences are Appendix Table 4.1).  The p53′ protein and subsequent mutants 
were purified as previously described.5, 30  
Electrophoretic mobility shift assay of p53′ and mutants.  For the 
determination of apparent KD values for each mutant, varied concentrations of each p53′ 
mutant were added to 25 nM Gadd45 response element DNA in the presence of 5 µM 
competitor DNA (5′-GGAAAAAAAAAAAAAAAAAAACC-3′) (IDT), 0.1% NP-40 
(Surfact-Amps NP-40, Thermo Scientific), 0.1 mg/mL BSA in p53 buffer (20 mM Tris-
HCl, pH 8.0, 20% glycerol, 100 mM KCl, 0.2 mM EDTA).  Samples were prepared at 
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ambient temperature, allowed to incubate for 20 minutes, and electrophoresed on a 10% 
TBE polyacrylamide native gel (Bio-Rad) in 0.5 x TBE buffer at 4 °C and 50 V for 1.5 h.  
DNA from the gel was transferred to Amersham Hybond-N nucleotide blotting paper 
(GE Healthcare) with a semidry electroblotter (Owl HEP-1) for 1 h at 175 mA in transfer 
buffer (25 mM Tris-HCl, pH 8.5, 200 mM glycine, 10% methanol).  The blots were 
exposed to a phosphorimaging screen (GE Healthcare), imaged with a STORM 820 or 
Typhoon FLA 9000 scanning system (GE Healthcare), and analyzed using ImageQuant 
TL and OriginPro.   
Samples prepared for p53 oxidation assays contained 25 nM p53 tetramer in the 
same conditions as listed above for the majority of the mutants.  Two mutants were 
assayed at higher p53 concentrations due to their higher apparent KD values:  Y236F-p53′ 
at 50 nM tetramer and C275S-p53′ at 125 nM tetramer.  Samples were made at 4 °C and 
irradiated in an ice bath for varying lengths of time (0, 5, 15, 30, 45, and 60 min) by solar 
simulator (ORIEL Instruments) with a UVB/UVC long-pass filter.  These samples were 
then analyzed by EMSA as described above and data were normalized to the 
corresponding unirradiated control.  The change in p53 binding was determined by 
monitoring the free DNA signal over the total DNA signal in each lane.  Data are an 
average of a minimum of three assay replicates, and the error is reported as the standard 
error of the mean. 
Selective cysteine labeling with iodoacetamide tags.  Proteins p53′, C275S-
p53′, and C141S-p53′ were studied to observe changes in cysteine oxidation state in 
DNA-bound p53 upon long range DNA CT.  An overview of the reaction scheme is 
depicted in Figure 4.3.  Each sample consisted of 100 µl 1.0 µM Gadd45 DNA (LC or 
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AQ), 2.0 µM p53′ monomer, 0.1% NP-40, 5.0 µM competitor DNA, in p53 buffer.  
Samples were prepared at 4 °C and allowed to incubate for 20 min prior to aliquoting.  
Samples for irradiation were aliquoted into a low profile 96-well PCR plate (Bio-Rad) at 
10 µL each, placed in an ice-water bath, and irradiated for 1 h by solar simulator with a 
UVB/UVC long-pass filter.  Unirradiated samples remained in the dark at 4 °C for the 
duration of the other irradiations.  Samples were adjusted to 6 M guanidine hydrochloride 
(GdmCl), by the addition of 8 M GdmCl in 20 mM Tris, 100 mM KCl, 0.2 mM EDTA, at 
pH 7.75. The samples were transferred to Amicon Ultra 0.5 ml 30 KDa cutoff centrifugal 
filter units (Millipore) and centrifuged at 13,000 x G for 15 min.  The concentrated 
samples, ~30 µl, were then treated with a 100-fold molar excess of iodoacetamide 
(Single-Use, Thermo Scientific) with respect to the number of cysteine residues present. 
The reaction was allowed to continue for 1 h in the dark, shaking at 250 rpm.  Samples 
were diluted with 6 M GdmCl and centrifuged, repeatedly, until the concentration of 
remaining iodoacetamide within the sample was at least 100-fold below the number of 
cysteine residues, and concentrated to ~30 µL.  Dithiothreitol (DTT) was added at a 10-
fold molar excess than the reactive species present in the sample, cysteine and remaining 
iodoacetamide, to reduce disulfides.  This reduction was allowed to incubate for 20 min 
at ambient temperature in the dark, shaking at 250 rpm.  The same molar concentration of 
Tris(2-carboxyethyl)phosphine (TCEP-Neutral, Calbiochem) as DTT was then added to 
further ensure disulfide reduction and allowed to incubate, as above, for another 20 min.  
Samples were diluted with 6 M GdmCl and centrifuged, repeatedly, until the 
concentration of remaining DTT and TCEP were at a molar concentration 1000-fold 
below the number of cysteine residues present and the total volume concentrated to ~30  
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FIGURE 4.3 — Procedure for 
differential thiol labeling of cysteine 
residues.  Examples of the labeling 
procedure are depicted for a fully 
reduced protein (Left) and its 
corresponding oxidized, disulfide-
containing counterpart (Right).  After 
oxidation from a distance through 
DNA CT, the protein sample is 
denatured in 6 M GdmCl and treated 
with iodoacetamide.  Cysteine 
residues in a reduced state will react 
with iodoacetamide (red), while 
cysteine residues participating in 
disulfide bonds remain chemically 
unavailable.  Removal of excess 
iodoacetamide followed by reduction 
of all disulfide bonds allow for 
accessibility of newly reduced thiol 
groups to react with the second 
13C2D2-iodoacetamide label (blue).  
The protein is then proteolytically 
digested, peptide fragments are 
analyzed on a QTRAP 6500 LC-
MS/MS, and peak areas are integrated 
in Skyline.  Representative 
chromatograms of the C124 
containing SVTCTYSPALNK peptide 
fragment from a p53′ sample set are 
shown as relative intensities of 
iodoacetamide (red) and 13C2D2IAA 
(blue) peptides detected.  The four 
traces represent LCD—light control 
dark, LCL—light control light, 
AQD—anthraquinone dark, and 
AQL—anthraquinone light.	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µL.  To each sample 13C2D2-iodoacetamide (Aldrich) in H2O was added at a 100-fold 
molar excess with respect to the cysteine residues and remaining reducing agents present.  
This reaction was allowed to continue for 4 h at ambient temperature, shaking at 250 
rpm, in the dark.  The samples were diluted using 100 mM Tris, pH 8.5, to lower the 
GdmCl concentration.  The sample was repeatedly diluted and centrifuged until the final 
GdmCl concentration was below 0.1 M GdmCl in a final sample volume of ~30 µL and 
dried in vacuo.  The dry sample pellet was dissolved in 40 µL of 8 M urea in 100 mM 
Tris-HCl, pH 8.5.  1 µL of 0.1 µg/µL of lysyl endopeptidase (WAKO) dissolved in 100 
mM Tris-HCl pH 8.5 was added to each sample and allowed to incubate for 4 h at 
ambient temperature in the dark.  The samples were subsequently diluted with 100 mM 
Tris-HCl, pH 8.5, to a final concentration of 2 M urea and adjusted to 1 mM CaCl2.  
Trypsin (1 µL of 0.5 µg/µL)(Promega) in water was added to each sample and allowed to 
incubate in the dark overnight at ambient temperature.  The following morning, each 
sample was adjusted to 5% formic acid to simultaneously inhibit protease activity and 
protonate tryptic peptides; samples were then dried in vacuo. Dry samples were 
suspended into 50 µL of 0.1% TFA and sonicated for 5 min.  Stagetips were made in-
house with Empore Extraction disk C-18 membranes (3M) for desalting the peptide 
samples.31  The stagetip was washed once with 100 µL of 80% acetonitrile in 0.1% TFA 
and twice with 100 µL 0.1% TFA prior to sample loading, centrifuging for 3 min at 3000 
rpm between each round.  Samples were loaded to the stagetip by centrifugation and then 
washed twice with 100 µL 0.1% TFA.  The sample was eluted with 100 µL of 80% 
acetonitrile in 0.1% TFA into fresh collection tube.  The eluent was dried in vacuo and 
stored at -20 °C until analysis.  
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Multiple reaction monitoring (MRM) mass spectrometry.  Each protein 
sample, 500 fmol per injection, was dissolved in 2% acetonitrile with 0.2% formic acid 
(FA).  To ensure consistency among sample sets and to help validate proper peak 
assignment by retention time, iRT peptide standards (BIOGNOSYS) were added. 
Samples were examined on the ABSciex QTRAP 6500 LC-MS/MS system, equipped 
with an Eksigent ekspert nanoLC 425 pump, ekspert nanoLC400 autosampler, ekspert 
cHiPLC, and Analyst software.  Samples were separated on a cHiPLC Chrom XP C18-
CL 3 µm trap column, 120Å (200 µm * 0.5 mm), inline with a cHiPLC Chrom XP C18-
CL 3 µm column, 120Å (75 µm * 150 mm) using a 45 min linear gradient of acetonitrile 
in 0.2% FA at a flow rate of 300 nL/min.  An unscheduled transition list of cysteine-
containing peptides with both respective iodoacetamide labels, as well as iRT peptide 
standards, was generated by Skyline and exported to the QTRAP for quantitation and are 
located in Appendix Table 4.2.32  Raw data files generated by the QTRAP were imported 
back into Skyline, where peak areas were then integrated and exported for further 
processing.  Observable and quantifiable peptide fragments include: C124—[121, 132] 
SVTCTYSPALNK, C135—[133, 138] LFCQLAK, C141—[140, 156] 
TCPVQLWVDSTPPPGTR, C182—[182, 196] CSDSDGLAPPQHLIR, and C275 and 
C277—[274, 280] VCACPGR.  Two cysteine-containing peptide fragments were 
unobservable in our methods due to unfavorable mass/charge of the fragments: C175—
[174, 180] RCPHHER, and C229, C238, and C242—[213, 248] 
HSVVVPYEPPEVGSDCTTIHYNYMC-NSSCMGGMNRR.  Various proteases were 
evaluated; however, this large peptide fragment could not be further cleaved due to the 
inherent amino acid sequence of p53′. 
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RESULTS 
Mutant p53′ affinity for the Gadd45 response element.   
To understand the chemistry of p53 oxidation from a distance through DNA CT, 
individual residues within the DNA-binding domain were selectively mutated.  We used 
a pseudo-wild-type p53, termed p53′, that incorporates three stabilizing mutations 
(M133L, V203A, and N268D) while remaining redox active.29  All other mutants studied 
were created by site directed mutagenesis of the p53′ plasmid.  The following cysteine 
residues were mutated to similarly sized but redox-inactive serine: C124, C135, C141, 
C182, C275, and C277.  Two other mutations studied include Y236F and N239Y.  These 
mutations were chosen since they are within close proximity to the cysteine residues in 
question and involve the addition or deletion of a similarly redox-active tyrosine (+0.9 
V).13  This cohort of p53 mutants was studied by EMSA to determine if any changes in 
binding affinity to the Gadd45 promoter site were evident without photooxidation.    
Each mutant protein was evaluated by EMSA and the apparent KD values were 
determined using varied concentrations of the p53′ mutants in the presence of 25 nM 
Gadd45 DNA (LC or AQ) in p53 buffer with 5 µM competitor DNA, 0.1% NP-40, and 
0.1 mg/mL BSA.  The determined apparent KD values are listed in Table 1.  The majority 
of the chosen mutations did not significantly change the binding affinity of these proteins 
to the Gadd45 promoter site as compared to p53′, with or without AQ.  The baseline of 
binding affinity is shown by p53′ with KD values of 1.6 ± 0.6 nM and 2.4 ± 1.1 nM of p53 
tetramer for LC and AQ, respectively.  C124S-p53′, C135S-p53′, C141S-p53′, and 
C277S-p53′ all share similar values as p53′ with apparent KD values below 5 nM p53′ 
tetramer.  Two mutants exhibited a slight decrease in affinity, at 9.7 ± 4.3 nM (LC) 
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TABLE 4.1 — Relative dissociation constants of mutant p53 bound to Gadd45 response element.	  
a. All mutants contain the stabilizing mutations M133L, V203A, and N268D. 
b. The apparent KD of p53′ (in tetramer units) was determined at 25 nM duplex, 5 µM dAdT, 0.1% 
NP-40, 0.1 mg/mL BSA in 20 mM Tris-HCl (pH 8.0), 20% glycerol, 100 mM KCl, and 0.2 mM 
EDTA at ambient temperature and the sample electrophoresed at 50 V on a 10% polyacrylamide 
gel in 0.5 × TBE at 4 °C. 	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and 8.2 ± 4.7 nM (AQ) tetramer for Y236F-p53′ and 15.1 ± 1.8 nM (LC) and 13.7 ± 4.4 
nM (AQ) tetramer for C182S-p53′.  Notably, the C275S-p53′ mutant displays severely 
attenuated affinity for the Gadd45 promoter site with apparent KD values of 56 ± 13 nM 
(LC) and 54 ± 8 nM (AQ).  
 
Oxidative dissociation of p53′ mutants through DNA CT.   
Additional EMSAs were employed to determine if any of these mutations altered 
the ability of p53′ to oxidatively dissociate from the Gadd45 promoter site.  Changes in 
p53′ binding to the Gadd45 promoter site with respect to irradiation time for each mutant 
were quantified and the results are shown in Figure 4.4, along with representative EMSA 
autoradiograms of C135-p53′ and C275S-p53′.  Most samples were composed of 25 nM 
p53′ tetramer and 25 nM Gadd45 DNA in the presence of 5 µM competitor DNA, 0.1% 
NP-40, 0.1 mg/mL BSA in p53 buffer.  Y236F-p53′ and C275S-p53′ were assayed at 
higher protein concentrations, 50 nM tetramer and 125 nM tetramer, respectively, to 
ensure protein-DNA binding due to their higher apparent KD values.  The fraction change 
in p53′ binding is determined as the free DNA signal divided by the sum of the free DNA 
and p53-bound DNA signals, normalized to the unirradiated control.  Each mutant was 
analyzed over a minimum of three replicates, with the error bars reflecting the standard 
error of the mean.  Previous experiments with the same construct, although with an 
intervening mismatch, showed an inhibition of oxidative dissociation, demonstrating that 
oxidation of p53 is DNA-mediated as opposed to involving a direct AQ-protein 
interaction.4  The behavior of p53′ is the standard to which each mutant is compared in 
Figure 4.4.  The EMSAs of p53′ oxidation reveal minimal oxidative dissociation from the  
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  FIGURE 4.4— Representative autoradiogram of the C135S-p53′ EMSA for the evaluation of 
mutant p53 activity on Gadd45-response element DNA.  The LC samples do not contain a 
photooxidant, while the AQ samples contain a 5′ covalently tethered anthraquinone.  The band 
intensities of free DNA and p53-bound-DNA are quantified with ImageQuant to determine 
changes in p53 occupancy upon irradiation.  EMSA analysis to determine the activity of 
mutant p53 bound to the Gadd45 promoter site upon distally induced DNA-mediated 
oxidation.  Solid markers represent AQ samples, while hollow markers represent LC samples.  
The data are representative of the average of a minimum of three replicates, with the error as 
the standard error of the mean. Samples contained 25 nM mutant p53′ tetramer and 25 nM 
Gadd45 DNA in the presence of 5 µM competitor DNA, 0.1% NP-40, and 0.1 mg/mL BSA in 
p53 buffer [20 mM Tris-HCl, pH 8.0, 20% glycerol, 100 mM KCl, and 0.2 mM EDTA].  Two 
mutants were assayed at higher protein concentrations due to their higher apparent KD values:  
Y236F-p53′ at 50 nM tetramer and C275S-p53′ at 125 nM tetramer. 	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LC-Gadd45 DNA (white), lacking the pendant AQ photooxidant.  However, the p53′ 
protein readily dissociated from the AQ-Gadd45 DNA (black), with 31.0 ± 1.2 % total 
p53′ dissociation upon 60 minutes of irradiation.  The LC-Gadd45 DNA samples across 
all of the mutants behave similarly, with minimal dissociation upon irradiation 
irrespective of additional mutations.  As compared to the p53′ protein, several mutants 
displayed a slight increase in the amount of dissociation from the AQ-Gadd45 DNA upon 
irradiation: C141S-p53′ (37.9 ± 2.7%), Y236F-p53′ (37.2 ± 2.3%), C135S-p53′ (34.0 ± 
5.0%), and C124S-p53′ (33.4 ± 8.6%).  Conversely, several mutants displayed a slight 
attenuation in the oxidative dissociation of p53 upon irradiation: C182S-p53′ (27.2 ± 
3.0%), N239Y-p53′ (25.5 ± 0.9%), and C277S-p53′ (22.6 ± 2.9%).  The most notable 
difference is observed with C275S-p53′, which reaches a maximum of only 13.3 ± 2.5% 
protein dissociation upon irradiation and is not within error of any other mutant. 
 
Analysis of cysteine oxidation in p53′ by mass spectrometry.   
Using multiple reaction monitoring (MRM) through sensitive analytical mass 
spectrometry, we directly examined the formation of disulfide bonds within p53′ and 
mutants from a distance through DNA CT.  An overview of the cysteine labeling protocol 
used to differentially label cysteine residues within p53 respective to oxidation state is 
shown in Figure 4.4.  Using this methodology, one can distinguish whether individual 
cysteine residues in the protein are participating in a disulfide bond.  After protein 
oxidation is induced from a distance by irradiation of the AQ-DNA, the protein is 
denatured in 6 M GdmCl and treated with iodoacetamide.  Reduced cysteine residues in 
p53′ will react with iodoacetamide (red), while oxidized cysteine residues participating in 
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disulfide bonds remain chemically unavailable.  Removal of excess iodoacetamide and 
subsequent reduction of all disulfide bonds allow for accessibility of the newly reduced 
cysteine residue thiol groups to react with the isotopically heavy 13C2D2-iodoacetamide 
(blue).  The protein is then proteolytically digested, desalted by C18 stagetip, and 
analyzed on a QTRAP 6500 LC-MS/MS.  Representative chromatograms of the acquired 
data for the peptide fragment containing C124 from a p53′ sample set are shown at the 
bottom of Figure 4.3.  The peak areas for both the iodoacetamide (red) and 13C2D2-
iodoacetamide (blue) labeled fragments were analyzed in Skyline, then directly 
compared.32  These data clearly show the trend toward the 13C2D2-iodoacetamide label 
with the AQL sample, whereas (LCD, LCL, and AQD, see Figure 4.3) were 
predominated by the isotopically light iodoacetamide label.   
Proteins p53′, C275S-p53′, and C141S-p53′ were studied by mass spectrometry to 
observe changes in cysteine oxidation in DNA-bound p53′ promoted at a distance 
through DNA CT.  We monitored the changes of cysteine residues in p53′ as our standard 
of comparison.  We also examined C275S-p53′ since it displayed the least oxidative 
dissociation by EMSA, and C141S-p53′ since C141 was previously implicated in 
potential disulfide formation through DNA CT.4  The floating-bar plots for each peptide 
fragment depict the fraction of the total signal of heavy and light modified species, 
totaling 1.0, as depicted in Figure 4.5 for p53′, Figure 4.6 for C141S-p53′, and Figure 4.7 
for C275S-p53′.  The fraction of 13C2D2-iodoacetamide labeled species is represented in 
positive values (black) and the fraction of iodoacetamide labeled species is represented in 
negative values (white).  These cumulative data sets are represented with individual 
protein mutants located in rows, and corresponding cysteine-containing peptide 
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fragments in columns.  Each sample set per mutant is composed of 4 variants, 
corresponding to DNA used (LC or AQ) and irradiation (D-dark, L-light).  The data 
represent the average of three replicates for C124, C135, C141, and C182 peptide 
fragments. The data for C275 and C277 represent the average of two replicates.  The 
error is represented as the standard error of the mean.  Peptide fragments corresponding 
to C176, C229, C238, and C242 could not be observed due to an unfavorable 
mass/charge ratio.  
A shift toward increased 13C2-D2-iodoacetamide labeling indicates that the 
cysteine of interest has become oxidized and is participating in a disulfide bond.  For p53′ 
and C141S-p53′ sample sets, the AQL samples show a marked increase in 13C2D2- 
iodoacetamide labeling over the LCD, LCL, and AQD control samples. The value (white) 
located within the AQL floating bar represents the percent change in heavy labeling of 
AQL sample with respect to the average of the corresponding LCD, LCL, and AQD 
controls.  The protein p53′ does indeed undergo chemical oxidation through DNA-
mediated DNA CT.  Interestingly, the C275S-p53′ sample set depicts a different interplay 
of oxidation states than observed for p53′ and C141S-p53′.  The overall baseline of 
13C2D2-iodoacetamide corresponding to the C135 and the C182 peptides are significantly 
higher across all four samples.  The C124, C141, and C277 peptides in C275S-p53′ 
behave more similarly to the other sample sets with a distinct, albeit a less intense, 
increase in the AQL samples as compared to the controls.  
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FIGURE 4.5 — Determination of cysteine oxidation states by MRM mass spectrometry of p53′ to 
observe changes in cysteine oxidation induced through DNA CT.  Cumulative data are depicted 
with individual mutant proteins localized in rows, and the corresponding cysteine-containing 
peptide fragments in columns.  The floating-bar plots for each peptide fragment are depicted as the 
fraction of the total signal of both heavy and light modified species, totaling 1.0.  The fraction of 
13C2-D2-iodoacetamide labeled species is represented in positive values (black) and the fraction of 
iodoacetamide labeled species is represented in negative values (white).  Each plot is composed of 
four samples: LCD—light control dark, LCL—light control light, AQD—anthraquinone dark, and 
AQL—anthraquinone light.  The value (white) located within the AQL floating bar represents the 
percent change in heavy labeling of the AQL sample with respect to the average of the 
corresponding LCD, LCL, and AQD controls.	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FIGURE 4.6 — Determination of cysteine oxidation states by MRM mass spectrometry of 
C141S-p53′ to observe changes in cysteine oxidation induced through DNA CT.  Cumulative data 
are depicted with individual mutant proteins localized in rows, and the corresponding cysteine-
containing peptide fragments in columns.  The floating-bar plots for each peptide fragment are 
depicted as the fraction of the total signal of both heavy and light modified species, totaling 1.0.  
The fraction of 13C2-D2-iodoacetamide labeled species is represented in positive values (black) and 
the fraction of iodoacetamide labeled species is represented in negative values (white).  Each plot 
is composed of four samples: LCD—light control dark, LCL—light control light, AQD—
anthraquinone dark, and AQL—anthraquinone light.  The value (white) located within the AQL 
floating bar represents the percent change in heavy labeling of the AQL sample with respect to the 
average of the corresponding LCD, LCL, and AQD controls. 
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FIGURE 4.7 — Determination of cysteine oxidation states by MRM mass spectrometry of 
C275S-p53′ to observe changes in cysteine oxidation induced through DNA CT.  Cumulative data 
are depicted with individual mutant proteins localized in rows, and the corresponding cysteine-
containing peptide fragments in columns.  The floating-bar plots for each peptide fragment are 
depicted as the fraction of the total signal of both heavy and light modified species, totaling 1.0.  
The fraction of 13C2-D2-iodoacetamide labeled species is represented in positive values (black) and 
the fraction of iodoacetamide labeled species is represented in negative values (white).  Each plot 
is composed of four samples: LCD—light control dark, LCL—light control light, AQD—
anthraquinone dark, and AQL—anthraquinone light.  The value (white) located within the AQL 
floating bar represents the percent change in heavy labeling of the AQL sample with respect to the 
average of the corresponding LCD, LCL, and AQD controls. 
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DISCUSSION 
Although much work has been done elucidating the redox-dependent binding of 
p53 to different promoter sites, relatively little is known about the chemistry of p53 
oxidation at a molecular level.  We are particularly interested in how the protein may be 
coupled into a charge transport pathway with DNA and how DNA-mediated oxidation of 
p53 may affect the affinity of p53 for individual promoter sites.  The conserved cysteine 
residues not involved in Zn2+ binding are of particular interest due to their biologically 
accessible oxidation potential, close proximity to DNA, and ability to form disulfide 
bonds.  In our studies, we sought to determine the role of various cysteine residues 
(C124, C135, C141, C182, C275, and C277) within the DNA-binding domain of p53 
through mutagenesis.  The cysteine-to-serine mutation was chosen, since serine is 
structurally similar to cysteine but does not contain the redox-active sulfur atom.  Two 
other mutations involving redox-active tyrosine residues (Y236F and N239Y) were 
investigated as well, as tyrosine has the same one-electron oxidation potential as cysteine 
(+0.9 V), also making it accessible to photooxidation by DNA-bound AQ.13 
 
Effect of select mutations on p53′ binding affinity.   
Each mutant of p53′ was first evaluated by determining changes in affinity for the 
Gadd45 promoter site.  All comparisons were made against the observed affinity of p53ʹ′ 
tetramer for Gadd45 DNA, which was determined to be 1.6 ± 0.6 nM and 2.4 ± 1.1 nM of 
tetramer for LC and AQ, respectively.  The majority of our chosen mutations did not 
significantly alter the binding affinity of these proteins to the Gadd45 promoter site.  
C124S-p53′, C135S-p53′, C141S-p53′, N239Y-p53′, and C277S-p53′ all share similar 
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affinities as p53′, with apparent KD values below 5 nM p53′ tetramer, indicating that 
C124, C135, C141, N239, and C277 do not play a significant role in modulating p53 
binding affinity to DNA.  Y236F-p53′ and C182S-p53′ both exhibited a slight decrease in 
affinity, with corresponding apparent KD values between 8-15 nM p53 tetramer.  This 
indicates that the integrity of Y236 and C182 within the protein may contribute to 
binding affinity through necessary DNA-protein contacts or protein-protein interactions 
in tetramer formation.  Notably, the C275S-p53′ mutant displays severely attenuated 
affinity for the Gadd45 promoter site with KD values of 56 ± 13 (LC) and 54 ± 8 nM 
(AQ).  This finding demonstrates that the integrity and likely positioning of C275 is 
necessary for the high affinity binding of p53 to promoter site DNA. 
 
Effect of select mutations on oxidative dissociation.   
How do these mutations affect the oxidative dissociation of DNA-bound p53? 
The behavior of p53′ is the standard to which each mutant was compared.  For p53′, 31% 
p53′ dissociation is seen relative to controls after 60 minutes of irradiation of DNA-
tethered AQ.  Oxidative dissociation from the AQ-Gadd45 DNA is equal to or slightly 
increased for C124S-p53′, C135S-p53′, C141S-p53′, and Y236F-p53′ upon irradiation.  
Slightly increased dissociation suggests that the integrity of these residues is not 
essential.  In contrast, several mutants did cause attenuation in oxidative dissociation.  
The C182S-p53′ mutation appears to slightly decrease oxidative dissociation.  The 
N239Y-p53′ mutation also shows a slight decrease in dissociation; since tyrosine has the 
same redox potential as cysteine and is within close proximity of the DNA, the added 
tyrosine residue may become oxidized, preventing electron hole migration to other 
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cysteine residues.12  Interestingly, while known to be a stabilizing mutation within p53, 
N239Y has been observed in colorectal cancer somatic cell mutations.29, 33, 34  It is 
noteworthy that the C277-p53′ mutant binds Gadd45 DNA with comparable affinity as 
p53′ but does not to dissociate as readily at 22% and not within error of p53′.  This result 
indicates that C277 may be a necessary element for the oxidative dissociation of p53, 
perhaps through coupling into the DNA CT pathway and initiating disulfide formation 
with the nearby C275.  Indeed, the most significant difference observed with the mutants 
is the severe attenuation of oxidative dissociation of C275S-p53′, with a maximum of 
only 13% dissociation.  Thus it is evident that C275 plays a critical role in the affinity of 
p53 for its promoter site as well as enabling oxidative dissociation.  Interestingly, the 
mutation of C275 has been observed in lung cancer.35  The attenuation of oxidative 
dissociation in both C275S and C277S suggests the possibility that these residues form a 
key disulfide bond upon oxidation.  The formation of a disulfide between C275 and C277 
would also remove DNA contacts, lowering DNA affinity overall, and enabling p53 
dissociation.  The observed amounts of oxidative dissociation of C275S-p53′ and C277S-
p53′ are not equivalent, indicating that these two residues are not phenocopies.  This 
variation is due to the location of the cysteine residues with respect to the DNA bases 
conveying the electron hole. 
 
Mass spectrometry results to characterize cysteine oxidation states.   
Mass spectrometry studies were carried out to understand the chemistry of DNA-
mediated p53 oxidation.  A differential-thiol labeling method was devised to determine 
the oxidation state of specific cysteine residues within p53.  The sequential use of 
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iodoacetamide, reducing agents, and isotopically distinct 13C2D2-iodoacetamide enables 
us to label cysteine residues depending on their respective oxidation state.  A shift toward 
greater 13C2D2-iodoacetamide labeling in comparison to controls, as monitored through 
MRM mass spectrometry, indicates oxidation of that residue and its disulfide 
participation.  We were able to study six of the ten cysteine residues present within the 
DNA-binding domain through this technique.  We were unable to detect C176 since it is 
located in a very small and highly charged peptide fragment [RCPHHER], resulting in an 
unfavorable mass/charge ratio.  Three cysteine residues (C229, C238, and C242) all 
reside within one extraordinarily large peptide fragment that 
[HSVVVPYEPPEVGSDCTTIHYNYMCN-SSCMGGMNRR] could not be further 
digested proteolytically and could therefore not be detected within the limits of our 
instrumentation.  The remaining six cysteine residues are readily detected and 
quantifiable.  However, C275 and C277 reside within the same peptide fragment, so 
secondary ion intensities were utilized to deconvolute mixed species containing both 
iodoacetamide and 13C2D2-iodoacetamide. 
It is important to note that these mass spectrometry data indicate directly that the 
DNA-bound p53′ protein can be oxidized from a distance through DNA-mediated CT. 
Residues bound to the DNA, and not those most accessible to solution, are oxidized, 
funneling oxidative damage from the DNA helix and into the protein.  This DNA-
mediated process promotes p53′ dissociation from the Gadd45 promoter site. 
The mass spectrometry data furthermore establish which cysteine residues are 
being oxidized from a distance through DNA CT.  In most cysteine residues observed for 
both the p53′ and the C141S-p53′ sample sets, the AQL samples show a marked increase 
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in 13C2D2-iodoacetamide labeling samples as compared to the LCD, LCL, and AQD 
controls.  Thus, cysteine oxidation resulting in disulfide bond formation is occurring 
among all observable cysteine residues within p53′ and C141S-p53′.  However, we are 
unable to determine whether the disulfide formation is occurring intramolecularly or 
intermolecularly through our methodologies.  Both p53ʹ′ and C141S-p53ʹ′ show very 
similar profiles of oxidation with a significant AQL-13C2D2-iodoacetamide increase in all 
observable cysteine residues: C124, C135, C141, C182, C275, and C277.  It should be 
noted that across all of the samples there is a baseline level of oxidation, indicating some 
disulfide presence in the protein prior to DNA CT.  Nonetheless it appears that the 
majority of the cysteines are in the reduced state.  Importantly, the fraction of 13C2D2-
iodoacetamide labeling is greatly increased upon oxidation, resulting from DNA CT.  
Removal of C141 through the C141S mutation does not appear to alter the DNA binding 
affinity, oxidative dissociation, or the ability to oxidize any other cysteine residues.  This 
suggests that oxidation of C141 may occur, but its presence is not necessary for 
modulation of p53′ binding affinity through DNA-mediated oxidation. 
The C275S-p53′ sample set depicts a different interplay of oxidation states than 
observed in either p53′ or C141S-p53′, however.  The overall baseline of 13C2D2-
iodoacetamide labeling for C135 and C182 peptide controls are high across all four 
samples, greater than 60%, and only show a slight increase in the AQL samples over the 
controls.  The C124, C141, and C277 peptides in C275S-p53′ behave more similarly to 
the other sample sets with a distinct, albeit less intense, increase in the AQL samples with 
respect to the controls.  The smaller shift toward 13C2D2-iodoacetamide labeling in the 
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AQL samples relative to the controls suggests that the absence of C275 disrupts the 
ability of oxidation to be transferred to the more internal residues. 
 
Oxidative dissociation of p53′ by disulfide formation.   
By applying the observed data to the network of cysteine residues within p53, we 
can consider how DNA-mediated oxidation of p53 may occur and how it may lead to 
changes in protein conformation that decrease affinity for DNA.  Reduced p53 binds as a 
tetramer to the Gadd45 promoter site.  Upon DNA oxidation, an electron hole will 
migrate through the π-stacked bases and localize to DNA sites of low redox potential, 
such as guanine.  This CT occurs on a timescale that is fast compared to irreversible 
reaction of guanine radicals.36  In the case of the Gadd45 promoter site, the low oxidation 
potential guanine sites are located within the purine region of the response element in 
close proximity to the p53 residue C277.  Since the redox potential of cysteine (+0.9 V) 
is lower than guanine (+1.29 V), the C277 residue tucked in the major groove near 
guanine can accept the electron hole, become oxidized, and lose its hydrogen bond to the 
major groove of DNA.13-16  Due to the solvent accessibility of C277 and its close 
proximity to C275, further oxidation of C277 by molecular oxygen would allow for loss 
of a second electron and result in disulfide formation between C277 and C275, located 
7.0 Å away.  Disulfide formation between these two residues would result in the loss of 
essential p53-DNA binding contacts, leading to a significant decrease in affinity, causing 
the dissociation of the oxidized p53 monomer, as is schematically depicted in Figure 4.8. 
Disulfide bonds are known to rearrange among other cysteine residues within 
close proximity of one another within proteins.37,38  Upon formation of the C277-C275 
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FIGURE 4.8 — Proposed disulfide formation within p53 via DNA CT based on the 3KMD 
crystal structure.21  Formation of the disulfide bond between C275 and C277 results in the loss 
of DNA response element contacts and is therefore most likely responsible for the loss of 
DNA binding affinity upon oxidation through DNA CT. 	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disulfide bond, a subsequent rearrangement could occur given the presence of many other 
reduced cysteine residues within close proximity.  If this were to occur, C275 would most 
likely form a disulfide with C135 (7 Å away).  This bond rearrangement would funnel the 
disulfide bond deeper into the protein and enable C277 to become reduced and possibly 
reestablish its H-bond to DNA.  The disulfide bond could then rearrange once more, 
resulting in one disulfide bond potentially residing among the inner triad of cysteine 
residues: C124, C135, and C141.  
Thus, well conserved cysteine residues of p53 provide a chemical platform 
through which genomic oxidative stress can be directly sensed.  Since p53 is a 
transcription factor presiding over the regulation of hundreds of human genes, the 
oxidative dissociation of p53 allows for a direct response in p53 gene regulation during 
times of genomic stress.  The extent of oxidative dissociation of p53 depends on the DNA 
sequence of the promoter site to which it is bound.5  Low redox potential guanine bases 
located in the purine region of the p53 promoter site allow for electron holes to localize at 
the DNA-protein interface and concomitantly oxidize p53.  The variability of bases 
within the promoter site, while fully conforming to the response element constraints, 
allows for a tuning of the redox potential at the DNA-protein interface.  The DNA 
sequence of the promoter site determines whether DNA-bound p53 will be able to accept 
an electron hole and respond to genomic stress.  The cysteine residues in the protein 
create a network, which is coupled to DNA, capable of accepting electron holes via DNA 
CT.  It is through p53 oxidation and disulfide formation that the affinity of p53 for DNA 
is decreased, leading to the observable oxidative dissociation of DNA-bound p53.   
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These results thus indicate that DNA-mediated oxidation of p53 is a chemically 
distinct mechanism for the cell to respond specifically to oxidative damage to the 
genome.  The oxidation of p53 through DNA CT resulting in disulfide formation within a 
protein is an exciting new chapter in the study of cellular signaling of oxidative stress and 
the response of p53. 
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Appendix 4.1: Primer sequences for site directed mutagenesis of the p53´ plasmid. 
 
 
Mutation Direction Primer Sequence (5´ to 3´) 
N239Y Original plasmid of stabilized p53 quadruple mutant from Fersht Lab containing M133L, V203A, N268D, and N239Y.1 
Reversion on the N239Y mutation was used to create the p53´ plasmid 
Y239N 
Forward 
Reverse 
CCA CTA CAA CTA CAT GTG TAA CAG TTC CTG CAT GG 
CCA TGC AGG AAC TGT TAC ACA TGT AGT TGT AGT GG 
C124S 
Forward GTC TGT GAC TTC CAC GTA CTC CCC 
Reverse GGG GAG TAC GTG GAA GT CACA GAC 
C135S 
Forward CAA GCT GTT TAG CCA ACT GGC C 
Reverse GGC CAG TTG GCT AAA CAG CTT G 
C141S 
Forward CCA ACT GGC CAA GAC CTC CCC TGT GC 
Reverse CAG CTG CAC AGG GGA GGT CTT GGC C 
C182S 
Forward GGC GCT GCC CCC ACC ATG AGC GCA GC 
Reverse GGA GGG GCC AGA CCA TCG CTA TCT GA 
Y236F 
Forward CCA TCC ACT ACA ACT TCA TGT GTA AC 
Reverse CTG TTA CACA TG AAG TTG TAG TGG AT 
C275S 
Forward 
Reverse 
GTG CGT GTT AGT GCC TGT CCT 
AGG ACA GGC ACT AAC ACG CAC 
C277S 
Forward 
Reverse 
GTG CGT GTT TGT GCC AGT CCT GGG 
CCC AGG ACT GGC ACA AAC ACG CAG 
 
 
 
1. Nikolova, P. V., Henckel, J., Lane, D. P., and Fersht, A. R. (1998) Semirational design of 
active tumor suppressor p53 DNA binding domain with enhanced stability. Proc. Natl. 
Acad. Sci. USA 95, 14675−14680. 
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Appendix 4.2: QTRAP 6500 LC-MS/MS Peptide Transitions. 
 
Peptide Q1 (amu) 
Q3 
(amu) 
Dwell 
Time 
(msec) 
Declustering 
Potential 
(V) 
Collision 
energy (V) 
C141S.TSPVQLWVDSTPPPGTR.+2y10.light 919.475782 1026.52145 20 98.1 42 
C141S.TSPVQLWVDSTPPPGTR.+2y9.light 919.475782 927.453036 20 98.1 42 
C141S.TSPVQLWVDSTPPPGTR.+2y8.light 919.475782 812.426093 20 98.1 42 
C141S.TSPVQLWVDSTPPPGTR.+2y6.light 919.475782 624.346386 20 98.1 42 
p53_3X.TC[CAM]PVQLWVDSTPPPGTR.+2y11.light 955.975092 1212.600763 20 100.8 43.3 
p53_3X.TC[CAM]PVQLWVDSTPPPGTR.+2y10.light 955.975092 1026.52145 20 100.8 43.3 
p53_3X.TC[CAM]PVQLWVDSTPPPGTR.+2y8.light 955.975092 812.426093 20 100.8 43.3 
p53_3X.TC[CAM]PVQLWVDSTPPPGTR.+2y6.light 955.975092 624.346386 20 100.8 43.3 
p53_3X.TC[CAM]PVQLWVDSTPPPGTR.+2y11.heavy 957.984724 1212.600763 20 100.8 43.3 
p53_3X.TC[CAM]PVQLWVDSTPPPGTR.+2y10.heavy 957.984724 1026.52145 20 100.8 43.3 
p53_3X.TC[CAM]PVQLWVDSTPPPGTR.+2y8.heavy 957.984724 812.426093 20 100.8 43.3 
p53_3X.TC[CAM]PVQLWVDSTPPPGTR.+2y6.heavy 957.984724 624.346386 20 100.8 43.3 
p53_3X.TC[CAM]PVQLWVDSTPPPGTR.+2y11.light 927.46436 1212.600763 20 98.7 42.2 
p53_3X.TC[CAM]PVQLWVDSTPPPGTR.+2y10.light 927.46436 1026.52145 20 98.7 42.2 
p53_3X.TC[CAM]PVQLWVDSTPPPGTR.+2y8.light 927.46436 812.426093 20 98.7 42.2 
p53_3X.TC[CAM]PVQLWVDSTPPPGTR.+2y6.light 927.46436 624.346386 20 98.7 42.2 
p53_3X.VC[CAM]AC[CAM]PGR.+2y6.light 410.18364 720.29159 20 61 23.6 
p53_3X.VC[CAM]AC[CAM]PGR.+2y5.light 410.18364 560.260942 20 61 23.6 
p53_3X.VC[CAM]AC[CAM]PGR.+2y4.light 410.18364 489.223828 20 61 23.6 
p53_3X.VC[CAM]AC[CAM]PGR.+2y3.light 410.18364 329.193179 20 61 23.6 
p53_3X.VC[CAM]AC[CAM]PGR.+2y6.heavy 414.202903 728.330116 20 61 23.6 
p53_3X.VC[CAM]AC[CAM]PGR.+2y5.heavy 414.202903 564.280205 20 61 23.6 
p53_3X.VC[CAM]AC[CAM]PGR.+2y4.heavy 414.202903 493.243091 20 61 23.6 
p53_3X.VC[CAM]AC[CAM]PGR.+2y3.heavy 414.202903 329.193179 20 61 23.6 
p53_3X.VC[CAM]AC[CAM]PGR.+2y6.light 353.162176 606.248662 20 56.9 21.6 
p53_3X.VC[CAM]AC[CAM]PGR.+2y5.light 353.162176 503.239478 20 56.9 21.6 
p53_3X.VC[CAM]AC[CAM]PGR.+2y4.light 353.162176 432.202364 20 56.9 21.6 
p53_3X.VC[CAM]AC[CAM]PGR.+2y3.light 353.162176 329.193179 20 56.9 21.6 
p53_3X.VC[CAM]AC[CAM]PGR.+2y6.light 412.193272 724.310853 20 61.2 23.7 
p53_3X.VC[CAM]AC[CAM]PGR.+2y5.light 412.193272 560.260942 20 61.2 23.7 
p53_3X.VC[CAM]AC[CAM]PGR.+2y4.light 412.193272 489.223828 20 61.2 23.7 
p53_3X.VC[CAM]AC[CAM]PGR.+2y3.light 412.193272 329.193179 20 61.2 23.7 
p53_3X.VC[CAM]AC[CAM]PGR.+2y5.light 412.193272 564.280205 20 61.2 23.7 
p53_3X.VC[CAM]AC[CAM]PGR.+2y4.light 412.193272 493.243091 20 61.2 23.7 
p53_3X.VC[CAM]AC[CAM]PGR.+2y6.light 414.202903 728.330116 20 61.3 23.8 
p53_3X.VC[CAM]AC[CAM]PGR.+2y5.light 414.202903 564.280205 20 61.3 23.8 
p53_3X.VC[CAM]AC[CAM]PGR.+2y4.light 414.202903 493.243091 20 61.3 23.8 
p53_3X.VC[CAM]AC[CAM]PGR.+2y3.light 414.202903 329.193179 20 61.3 23.8 
C275S.VSAC[CAM]PGR.+2y6.light 373.68433 647.29297 20 58.4 22.3 
C275S.VSAC[CAM]PGR.+2y5.light 373.68433 560.260942 20 58.4 22.3 
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C275S.VSAC[CAM]PGR.+2y4.light 373.68433 489.223828 20 58.4 22.3 
C275S.VSAC[CAM]PGR.+2y3.light 373.68433 329.193179 20 58.4 22.3 
C275S.VSAC[CAM]PGR.+2y6.heavy 375.693962 651.312233 20 58.4 22.3 
C275S.VSAC[CAM]PGR.+2y5.heavy 375.693962 564.280205 20 58.4 22.3 
C275S.VSAC[CAM]PGR.+2y4.heavy 375.693962 493.243091 20 58.4 22.3 
C275S.VSAC[CAM]PGR.+2y3.heavy 375.693962 329.193179 20 58.4 22.3 
C275S.VSAC[CAM]PGR.+2y6.light 345.173598 590.271506 20 56.3 21.3 
C275S.VSAC[CAM]PGR.+2y5.light 345.173598 503.239478 20 56.3 21.3 
C275S.VSAC[CAM]PGR.+2y4.light 345.173598 432.202364 20 56.3 21.3 
C275S.VSAC[CAM]PGR.+2y3.light 345.173598 329.193179 20 56.3 21.3 
iRT.LGGNETQVR.+2y8.light 487.256705 860.42207 20 66.6 26.4 
iRT.LGGNETQVR.+2y4.light 487.256705 503.293622 20 66.6 26.4 
iRT.AGGSSEPVTGLADK.+2y8.light 644.822606 800.451245 20 78.1 32.1 
iRT.AGGSSEPVTGLADK.+2y6.light 644.822606 604.330067 20 78.1 32.1 
iRT.VEATFGVDESANK.+2b8.light 683.827888 819.38831 20 81 33.5 
iRT.VEATFGVDESANK.+2y9.light 683.827888 966.452701 20 81 33.5 
iRT.YILAGVESNK.+2y8.light 547.298038 817.441408 20 71 28.6 
iRT.YILAGVESNK.+2y6.light 547.298038 633.32023 20 71 28.6 
iRT.TPVISGGPYYER.+2y9.light 669.838059 1041.499986 20 79.9 33 
iRT.TPVISGGPYYER.+2y8.light 669.838059 928.415922 20 79.9 33 
iRT.TPVITGAPYYER.+2y8.light 683.853709 956.447222 20 81 33.5 
iRT.TPVITGAPYYER.+2y7.light 683.853709 855.399543 20 81 33.5 
iRT.GDLDAASYYAPVR.+2y8.light 699.338423 926.473043 20 82.1 34 
iRT.GDLDAASYYAPVR.+2y7.light 699.338423 855.435929 20 82.1 34 
iRT.DAVTPADFSEWSK.+2y9.light 726.835713 1066.484001 20 84.1 35 
iRT.DAVTPADFSEWSK.+2y9+2.light 726.835713 533.745639 20 84.1 35 
iRT.TGFIIDPGGVIR.+2y7.light 622.853512 713.394064 20 76.5 31.3 
iRT.TGFIIDPGGVIR.+2y6.light 622.853512 598.367121 20 76.5 31.3 
iRT.GTFIIDPAAIVR.+2y8.light 636.869162 854.509428 20 77.5 31.8 
iRT.GTFIIDPAAIVR.+2y6.light 636.869162 626.398421 20 77.5 31.8 
iRT.FLLQFGAQGSPLFK.+2y10.light 776.929751 1051.557107 20 87.8 36.8 
iRT.FLLQFGAQGSPLFK.+2y9.light 776.929751 904.488693 20 87.8 36.8 
p53.ELNEALELK.+2y7.light 529.790046 816.446159 20 69.7 27.9 
p53.ELNEALELK.+2y6.light 529.790046 702.403232 20 69.7 27.9 
p53.ELNEALELK.+2y5.light 529.790046 573.360639 20 69.7 27.9 
p53.ELNEALELK.+2y4.light 529.790046 502.323525 20 69.7 27.9 
p53.SVTC[CAM]TYSPALNK.+2y8.light 670.829377 893.472708 20 80 33 
p53.SVTC[CAM]TYSPALNK.+2y7.light 670.829377 792.42503 20 80 33 
p53.SVTC[CAM]TYSPALNK.+2y6.light 670.829377 629.361701 20 80 33 
p53.SVTC[CAM]TYSPALNK.+2y5.light 670.829377 542.329673 20 80 33 
p53.SVTC[CAM]TYSPALNK.+2y8.heavy 672.839008 893.472708 20 80 33 
p53.SVTC[CAM]TYSPALNK.+2y7.heavy 672.839008 792.42503 20 80 33 
p53.SVTC[CAM]TYSPALNK.+2y6.heavy 672.839008 629.361701 20 80 33 
p53.SVTC[CAM]TYSPALNK.+2y5.heavy 672.839008 542.329673 20 80 33 
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p53.SVTC[CAM]TYSPALNK.+2y8.light 642.318645 893.472708 20 77.9 32 
p53.SVTC[CAM]TYSPALNK.+2y7.light 642.318645 792.42503 20 77.9 32 
p53.SVTC[CAM]TYSPALNK.+2y6.light 642.318645 629.361701 20 77.9 32 
p53.SVTC[CAM]TYSPALNK.+2y5.light 642.318645 542.329673 20 77.9 32 
p53.LFC[CAM]QLAK.+2y6.light 440.241481 766.391622 20 63.2 24.7 
p53.LFC[CAM]QLAK.+2y5.light 440.241481 619.323208 20 63.2 24.7 
p53.LFC[CAM]QLAK.+2y3.light 440.241481 331.233982 20 63.2 24.7 
p53.LFC[CAM]QLAK.+2y6+2.light 440.241481 383.699449 20 63.2 24.7 
p53.LFC[CAM]QLAK.+2y6.heavy 442.251112 770.410885 20 63.2 24.7 
p53.LFC[CAM]QLAK.+2y5.heavy 442.251112 623.342471 20 63.2 24.7 
p53.LFC[CAM]QLAK.+2y3.heavy 442.251112 331.233982 20 63.2 24.7 
p53.LFC[CAM]QLAK.+2y6+2.heavy 442.251112 385.70908 20 63.2 24.7 
p53.LFC[CAM]QLAK.+2y6.light 411.730749 709.370158 20 61.1 23.7 
p53.LFC[CAM]QLAK.+2y5.light 411.730749 562.301744 20 61.1 23.7 
p53.LFC[CAM]QLAK.+2y3.light 411.730749 331.233982 20 61.1 23.7 
p53.LFC[CAM]QLAK.+2y6+2.light 411.730749 355.188717 20 61.1 23.7 
p53.C[CAM]SDSDGLAPPQHLIR.+3y7.light 555.938627 860.510097 20 71.6 27.8 
p53.C[CAM]SDSDGLAPPQHLIR.+3y6.light 555.938627 763.457333 20 71.6 27.8 
p53.C[CAM]SDSDGLAPPQHLIR.+3y8+2.light 555.938627 466.277243 20 71.6 27.8 
p53.C[CAM]SDSDGLAPPQHLIR.+3y7+2.light 555.938627 430.758686 20 71.6 27.8 
p53.C[CAM]SDSDGLAPPQHLIR.+3y7.heavy 557.278382 860.510097 20 71.6 27.8 
p53.C[CAM]SDSDGLAPPQHLIR.+3y6.heavy 557.278382 763.457333 20 71.6 27.8 
p53.C[CAM]SDSDGLAPPQHLIR.+3y8+2.heavy 557.278382 466.277243 20 71.6 27.8 
p53.C[CAM]SDSDGLAPPQHLIR.+3y7+2.heavy 557.278382 430.758686 20 71.6 27.8 
p53.C[CAM]SDSDGLAPPQHLIR.+3y7.light 536.931473 860.510097 20 70.3 26.8 
p53.C[CAM]SDSDGLAPPQHLIR.+3y6.light 536.931473 763.457333 20 70.3 26.8 
p53.C[CAM]SDSDGLAPPQHLIR.+3y8+2.light 536.931473 466.277243 20 70.3 26.8 
p53.C[CAM]SDSDGLAPPQHLIR.+3y7+2.light 536.931473 430.758686 20 70.3 26.8 
 
